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Motor neurons of the spinal cord and hindbrain are responsible for translating neural 
commands into movements. For the execution of smooth movements, it is necessary that 
motor neuronal impulses are in turn translated into the gradual build-up of muscle force. 
This task is achieved by the diversification of motor neurons into a range of ‘slow’ to ‘fast’ 
types that are recruited by presynaptic activity according to the amount and manner of force 
they generate in the muscle. During embryonic development motor neurons are generated 
from neural progenitor cells residing in the ventral neural tube. A lot of information has 
become available in recent years about how the motor neuron progenitors are specified and 
how motor neurons differentiate into different ‘positional identities’ according to the specific 
muscles or muscle groups they supply. However, very little is known about how the motor 
neurons diversify into the different slow and fast types required for the automated gradation 
and task-dependent application of muscle force. 
 
Dlk1, a type1 transmembrane protein, was recently identified as a determinant of motor 
neuron functional diversification by promoting fast motor neuron properties. Howbeit, the 
signalling mechanisms that allow Dlk1 to alter gene expression and promote fast motor 
neuron properties still remained unresolved. The present thesis attempted to dissect the 
signalling mechanism in a stepwise fashion starting from the plasma membrane, where the 
Dlk1 protein resides, to the nucleus where it affects gene expression. As a starting point, 
the supervisor’s laboratory had identified the Notch and NFATc4 as interacting partners of 
Dlk1. Knowing that Notch is a principal player in generation of cellular diversity throughout 
development while NFATc4 is a transcription factor that shuttles between cytosol and 
nucleus, I divided my study into two parts. In the first part of the thesis, I used biochemical 
and immunohistochemical assays to resolve the physical interaction between the Dlk1 
extracellular segment with Notch, its impact on Notch activation by canonical ligands and 
its influence on motor-neurogenesis. In the second part of my study, I show that Dlk1 is 
cleaved intracellularly and that the resulting Dlk1 intracellular segment interacts with 
NFATc4. My study also indicates the transcriptional regulation of Dlk1 target genes by 
NFAT. With the help of electrophysiological recordings in genetically manipulated chick 
spinal cord, I further found that suppressing NFAT activity alters the physiological properties 
of motor neurons. The result of my studies thus give rise to a model according to which 
Dlk1, by physically connecting Notch and NFAT signalling pathways, directly connects 







2.1 Specification of Spinal Neurons 
 
Neurons in the spinal cord (spinal neurons) have two important roles: the neurons in dorsal 
spinal cord relay sensory information to the brain while the ventral spinal neurons integrate 
descending and proprioceptive sensory input and generate motor outputs (Jessell 2000). 
The specification of these spinal neurons, after neural induction, depends on two basic 
signalling systems along the rostrocaudal and dorsoventral axes of the neural tube 
(Fig.2.1a). A rostrocaudal signalling gradient generates the main subdivisions of central 
nervous system (CNS) from rostral forebrain to caudal spinal cord. On the other hand, 
dorsoventral signalling gradient generates cell type diversity within each rostrocaudal 
subdivision. In addition, local signals among developing neurons are thought to establish 
the complete set of neuronal subtypes. 
 
The rostrocaudal signalling axis originates from the primitive streak during the gastrula 
stage of embryo and from the posterior paraxial mesoderm. Among these signals, 
increasing levels and convergent actions of fibroblast growth factors (FGFs), bone 
morphogenetic proteins (BMPs), retinoids and Wnts promote increasingly caudal neural 
characteristics. High levels of these proteins are therefore found in the region of the neural 
plate giving rise to the spinal cord (Stern 2005). Studies in chick has shown that at initial 
stages of gastrulation (stage 3: 10-12 hours after incubation of eggs), prospective neural 
cells need exposure to paraxial mesoderm caudalizing (PMC) activity and FGFs for generic 
caudal character. Later at stage 4 of chick embryonic development, retinoids become 
important to specify the progenitor cells into caudal spinal characteristics (Durston, van der 








Fig.2.1a Simplified Rostrocaudal and Dorsoventral signalling system in spinal cord 
After spinal cord formation, the combinatorial actions of Retinoids and FGFs (originating from 
paraxial mesoderm) gradient activate different HoxC genes and thus several segments of spinal cord 
from rostral end to caudal end are formed. Each of those segments is exposed to Shh (purple) and 
BMP (blue) gradients along dorsoventral axis. The gradient of Shh and BMP define the positioning 
of 12 neuronal progenitor domains (green, pink and brown). 
 
 
As a result of chronological exposure to these signalling mechanisms with combinatorial 
actions of homeodomain proteins (Hox-proteins), the spinal cord eventually becomes sub-
divided into four broad segments: Cervical, Brachial, Thoracic and Lumbar (Fig. 2.1b). 
These spinal segments are defined by the combinatorial expression of Hox transcriptions 
factors, the boundaries of which become further sharpened by cross-repressive actions 










Fig.2.1b Segmentation of mouse spinal cord by various Hox genes 
Spinal cord segments are broadly classified into five different levels based on anatomical location. 
Spinal segments in neck region are called as Cervical. Around the level of forelimbs, spinal cord is 
thicker and is termed as Brachial, while the segments at hind limb level are referred to as Lumbar 




Spinal neurons differentiate into several neuronal subtypes along dorsoventral axis. During 
the neural tube stage of embryonic development, commissural and association neurons 
differentiate in the dorsal half of the caudal neural tube while in ventral half, motor neurons 
(MNs) and interneurons differentiate. The differentiation of ventral neuronal subtypes 
depends on signals from the axial mesoderm, the notochord which lies beneath the ventral 
neural tube. Later on these signals are provided by floor plate cells which are located at 
extreme ventral midline within the spinal cord (Placzek 1995). Sonic hedgehog (Shh) is the 
principal morphogenetic signal secreted by notochord and floor plate cells and is the main 
determinant of ventral neural patterning (Patten and Placzek 2000). Shh is a diffusible 
molecule that forms a concentration gradient and affects differently on the cells of the 
developing embryo depending on its concentration. However, Shh signalling does not 
contribute in dorsal neuronal subtype generation. Dorsal identities are set by bone 
morphogenic proteins (BMP) signalling from the epidermis, which then promotes the 
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formation of the roof plate (Liem, Jessell et al. 2000). Retinoic acid (RA) produced by 
somites also controls dorsoventral cell identity (Pierani, Brenner-Morton et al. 1999). These 
morphogen gradients establish 12 progenitor domains giving rise to seven dorsal 
interneuron progenitor domains, four ventral interneuron progenitor domains (p0, p1, p2 




2.2 Ventral Patterning of Spinal Cord and Motor Neuron development 
 
MNs are clustered into motor columns in ventral spinal cord and are most diverse neuronal 
subclass in the spinal cord. The concentration of Shh protein within the ventral-to-dorsal 
gradient defines the position in which ventral neuron types are generated. The gradient of 
Shh signalling is interpreted by two classes of homeodomain proteins: class I and class II 
(Briscoe, Pierani et al. 2000). Depending on its concentration, Shh signalling suppresses 
class I homeodomain proteins (Pax7, Dbx1, Dbx2, Irx3 and Pax6) (Lu, Shashikant et al. 
1996, Shoji, Ito et al. 1996, Mastick, Davis et al. 1997, Mansouri and Gruss 1998, Pierani, 
Moran-Rivard et al. 2001) while activating class II proteins (Nkx6.1and Nkx2.2) (Briscoe, 
Sussel et al. 1999, Sander, Paydar et al. 2000) expression, thus creating a grid of cells 
exposed to different levels of Shh and homeodomain proteins. Different combinations of 
homeodomain proteins, induced or repressed by Shh, thereby define boundaries of the five-
neural progenitor (p) domains (p0, p1, p2, pMN and p3) and corresponding post-mitotic 
neurons (V0, V1, V2, MN and V3). Out of five subtypes of ventral neurons generated V0-
V3 represent different ventral interneurons and MN represent motor neurons. Apart from 
the homeodomain proteins, basic helix-loop-helix (bHLH) proteins also play important role 
in ventral patterning but their expression is thought to be under the regulation of Shh-
controlled homeodomain proteins. 
 
Generation of the motor neurons is restricted to pMN progenitor domain by combinatorial 
action of Pax6 and Nkx6.1 which inhibit Nkx2.2, and Dbx2 respectively and together activate 
expression of the basic helix-loop-helix (bHLH) protein, Olig2 (Marquardt and Pfaff 2001, 
Novitch, Chen et al. 2001). Olig2 in turn co-ordinately activates expression of the proneural 
bHLH transcription factor Neurogenin2 (Ngn2) (Lee, Lee et al. 2005). As Ngn2 accumulates 
in some of the pMNs it drives them from the progenitor state towards post-mitotic MNs by 
promoting cell cycle exit, while suppressing Notch signalling and glial fates. Later Olig2 and 
Ngn2 expressions are downregulated after initiating the expression of the LIM 
homeodomain proteins Hb9 and Isl1 that promote MN specification. Hb9 stimulates its own 
expression and implements an MN-specific gene expression program by inducing 
expression of Islet1, Islet2, Lhx3 and ChAT which provide MNs independence from the Shh 
and retinoid signalling (Tanabe, William et al. 1998). The pMN domain remains active after 
an initial phase of MN generation, but switches to the generation of oligodendrocytes 







Fig.2.2a Ventral Patterning in the Spinal cord  
Scheme illustrating the generation of ventral spinal progenitor domains. Shh secreted from the 
notochord and the floor plate make a ventral-high, dorsal-low gradient within ventral spinal cord 
(purple dots). Shh represses the Class-I homeodomain proteins (blue) (Pax7, Dbx1, Dbx2, Irx3, 
Pax6) and induces the Class-II homeodomain proteins (green) (Nkx6.2, Nkx6.1, Nkx2.2) and later 
bHLH protein Olig2 (light green). The cross-repressive activity of Class I and II proteins give rise to 
5 progenitor domains (p0, p1, p2, p3 and pMN). 
 
 
All spinal motor neurons originate from single progenitor domain but with further 
development, they acquire many subtype identities. The motor neuron subtypes can be 
categorised on basis of anatomical positions or based on functional and physiological 
differences. Anatomically motor neurons are divided into four motor columns along the 
rostrocaudal axis as shown in figure 2.2b. The medial motor column (MMC) present 
throughout the spinal cord innervates axial musculature. The lumbar motor columns (LMCs) 
are present only at brachial and lumbar levels of spinal cord and innervate limbs. The other 
two motor columns, the hypaxial motor column (HMC) and the preganglionic chain (PGC) 
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Fig.2.2b Positions of Motor Columns Along the Spinal Cord 
Relative representation of different motor columns along the axis of spinal cord. Only one side of 
motor columns are shown, same amount of motor columns also exists in other half of spinal cord. 
The medial motor column (green) is present throughout the spinal cord at all levels. The 
Preganglionic Chain (yellow) and Hypaxial Motor Column (blue) are present only at thoracic levels 






2.3 Functional Diversification of Motor Neurons 
 
Motor neuron diversity is a functional necessity for precise control over muscle contraction 
during complex movements, therefore all MNs are not functionally equal. MNs are not only 
diverse but also segregated and grouped into different muscle specific motor pools. Based 
on different axonal conduction velocities and firing patterns, MNs are classified as alpha 
(), gamma () and beta () MNs (Burke, Levine et al. 1973). While alpha MNs innervate 
only extrafusal muscle fibres and receive direct Ia (sensory fibre) inputs from proprioceptive 
neurons, the gamma MNs innervate only intrafusal muscle fibres in muscle spindles and 
lack Ia inputs. The beta MNs innervate both intrafusal and extrafusal muscle fibres but very 
little is known about their physiological properties. The electrophysiological difference 
between alpha and gamma MNs lies in axonal conducting velocities which also led to their 
nomenclature. The alpha MNs have faster conducting axons and are responsible for force 
generation in muscles during movement while gamma MNs have slower conducting axons 
and instead of contributing in force generation, they modulate the sensitivity of the muscle 
spindle stretch receptors by controlling intrafusal fibre contractility. Since there are several 
kinds of extrafusal and intrafusal muscle fibres known, it is intuitive to consider that a 
corresponding number of functional types of MNs exist. 
 
Muscle spindles have two major kinds of intrafusal fibres i.e. nuclear bag fibres (with 
relatively greater length and larger diameter) and nuclear chain fibres (with relatively shorter 
length and smaller diameter). Nuclear bag fibres are further classified into bag1 fibre 
contracting slowly and bag2 fibres which contracts faster. The two functional subtypes of 
gamma MNs are the gamma dynamic neurons that innervate only bag1 fibres and the 
gamma static innervate bag2 fibres and chain fibres. However, neither anatomically nor 
electro-physiologically or even at the molecular level, the gamma subtypes can be 
differentiated from each other. 
 
Extrafusal muscle fibres are categorised into three types based on their ATPase reactivity 
pattern i.e. type IIB, IIA and I and they can also be differentiated by Myosin heavy chain 
isoform expression. These three fibre types have contrasting physiological properties in 
terms of mitochondrial content, fatigue resistance and force generation. A given alpha MN 
only innervates muscle fibres of a single type and hence alpha MNs are categorised into 
10 
 
three types corresponding to the kind of extrafusal fibres they innervate i.e. ‘slow’, 





modified from (Manuel and Zytnicki 2011) 
 
Fig.2.3 Functional Subclasses of MNs 
Cartoon of location of MNs (MNs) in transverse section of spinal cord (top) and different kinds of 
MNs innervating their target muscle fibres (below). FF-type -MNs innervate IIB fibres. FR -MNs 
innervate IIA fibres. S-type -MNs innervate type I muscle fibres. -MNs innervate both extra- and 
intrafusal muscle fibres. -static MNs innervate either type IIA or IIB extrafusal fibres and the 
intrafusal bag2 fibre. -dynamic MNs innervate type I extrafusal muscle fibres and the intrafusal bag1 
fibre. -MNs are smallest in size and innervate exclusively intrafusal muscle fibres. -static MNs 
innervate the intrafusal bag2 fibre and/or the nuclear chain fibres. -dynamic MNs innervate the 
intrafusal bag1 fibre. 
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Also, the electrophysiological properties of the alpha MN types precisely match to the 
contractile properties of their muscle fibre target (Fig.2.3). Slow contracting type I fibres are 
innervated by slow alpha (S) MNs with relatively lower rheobases and lower firing 
frequencies. The fastest alpha (FF) MNs, in contrast, possess higher rheobase and 
highest firing frequencies among the alpha MN types and supply to the fast contracting 
fatigable type IIB fibres. Similarly, the alpha MNs innervating the fast fatigue resistant type 
IIA fibres are thought to show intermediate electrophysiological properties. 
 
The innervation pattern of the different MNs and the expression of combinations of 
membrane receptors and ion channels that together determine membrane electrical 
properties of MNs likely depend on well-regulated developmental pathways involving 
complex molecular signals. However, only a few of these signals are known so far (Table 
2.3). Certain proteins like α3 subunit of the Na+, K+ ATPase (Dobretsov, Hastings et al. 
2003), Err3 (Friese, Kaltschmidt et al. 2009), Gfrα1 (Shneider, Brown et al. 2009) and Wnt7a 
(Ashrafi, Lalancette-Hebert et al. 2012) have been recently reported as gamma MN 
markers. For alpha MNs the molecular markers are even fewer i.e. NeuN and Osteopontin 
(OPN) (Misawa, Hara et al. 2012). The discovery of concrete molecular markers is of utmost 
importance for elucidating the critical steps during locomotion and verifying the importance 
of different subtypes of MNs at each of those critical steps. The latest advancement in this 
direction was made in 2014 after the discovery of a transmembrane protein, delta homolog1 
(Dlk1) as a marker for fast alpha MN and the first determinant of MN functional 
diversification identified so far. (Muller, Cherukuri et al. 2014). 
 
Properties αFF αFR αS   
Target Muscle 
fibre 




Fibres Only Extrafusal fibres 
Membrane Input 
Resistance 
High Intermediate Low Intermediate Low 
Order of 
Recruitment 










High NeuN, OPN Low NeuN 
Table 2.3 Properties and Molecular Markers of MNs Subtypes 
12 
 
2.4 Dlk1 as a Determinant of Motor Neuron Functional Diversification 
 
Delta-like 1 homolog (Dlk1) is a type 1 transmembrane protein constituted with a signal 
peptide for the secretory pathway, six epidermal growth factor (EGF) like repeats, a 
transmembrane region and a short cytoplasmic C-terminus. Its juxta-membrane region has 
a TACE (ADAM17)-mediated cleavage site which in some contexts seems to create a 
secretory soluble form of Dlk1 (Wang and Sul 2006). This protein was discovered 
independently several times and given different names and was reported as inhibitor of 
adipogenesis (Smas and Sul 1993), promoter of muscle development (Charlier, Segers et 
al. 2001), regulator of B cell maturation (Raghunandan, Ruiz-Hidalgo et al. 2008), tumour-
suppressor (Li, Forman et al. 2005, Kawakami, Chano et al. 2006) and regulator of 
neurogenesis (Ferron, Charalambous et al. 2011). 
 
Although expression of Dlk1 in central nervous system and its putative roles in 
differentiation of neurons was known for more than a decade (Jensen, Meyer et al. 2001), 
nothing was known or discussed about its role in neuronal development until recently. In 
2014, it was shown that Dlk1 is expressed in one third population of spinal motor neurons 
and that its expression is important to promote fast MN properties. The population of MNs 
which express Dlk1 turn out to be both Hb9 and NeuN positive, with larger soma sizes 
indicating that Dlk1 expressing MNs are alpha MNs. Furthermore, in chicken spinal cord, 
overexpression of Dlk1 shifts the population of MNs towards ‘fast’ biophysical signature. 
Conversely, in Dlk1 knock-out mice, MNs fail to acquire the electrophysiological properties 
that normally characterize fast alpha MNs. Consequently, Dlk1 knock out mice which show 
reduced peak force generation during running tasks (Muller, Cherukuri et al. 2014). 
 
The exact mechanisms through which Dlk1 promotes fast MN signature remains unknown. 
However, Dlk1 is necessary to promote fast MN specific gene expression including the 
neural activity modulator KCNG4, while there is evidence that Dlk1 acts through inhibition 
of Notch (Muller, Cherukuri et al. 2014). Also, it has been clearly shown that only MNs over-
expressing Dlk1, but not the adjacent ones, exhibit fMN properties suggesting that Dlk1 acts 
cell-autonomously to promote fast MN properties (Muller, Cherukuri et al. 2014). Dlk1 in 
principle could act through multiple pathways, involving interactions of different proteins with 
its extracellular segment and intracellular segment and initiating different signalling 
pathways which influence various properties of the cell. A secondary structure of Dlk1 and 







Fig.2.4 Dlk1 Transmembrane Protein Alters Motor Neuron Properties 
Dlk1 is a transmembrane protein with 6 EGF-like repeats and can exhibit cis-interactions via EGF 
domain. Dlk1 is cleaved by metallopeptidases (ADAM/TACE) and extracellular segment is secreted. 
Although exact signalling mechanism is unknown but Dlk1 alters gene transcription and changes the 
ion channel levels at membrane which ultimately changes motor neuron properties towards fast MNs. 
(A) shows the possible cis-interaction with Notch as speculated in literature. (B) and (C) depicts 




2.5 Notch Signalling and Dlk1 as a Ligand of Notch 
 
Notch is a single pass type I transmembrane receptor protein which mostly exists as a 
heterodimer after maturation (Blaumueller, Qi et al. 1997) (Fig 2.5a). For three decades 
after cloning of Notch, a lot have been studied, discovered and outlined about the Notch 
signalling pathway and its functions which relates to almost every field of biological science. 
Notch signalling is an interface for short range cell-to-cell communication. Interestingly, 
Notch signalling is irreversible and each Notch molecule signals only once without 
amplification by secondary messenger cascades (Kopan and Ilagan 2009). Notch signalling 
can promote or suppress proliferation, acquisition of specific cell fates, cell death and 
activation of differentiation programs throughout development of an organism and after 
maturation during self-renewal. 
 
During canonical Notch signalling, a canonical Notch ligand activates the mature receptor 
by trans- (cell-to-cell) interaction which leads to cleavage of Notch and generation of a 
Notch intracellular domain (NICD). NICD then translocates to the nucleus via unknown 
mechanism where it binds to a partner, the CSL protein, to affect transcription of genes (Fig. 
2.5a). The canonical Notch ligand comprise several paralogues of the Jagged and Delta 
type I transmembrane protein that acts through EGF repeat 11-12 of Notch and differ in 
their structural domains and interaction with Notch (Fig. 2.5b). The jagged ligands interact 
via both DSL (Delta, Serrate and Lag2) and DOS (Delta and OSM-11-like) domain while 
delta ligands (except DLL1) interact only via DSL domain. 
 
Apart from these canonical Notch ligands, non-canonical Notch ligands interact via different 
regions of Notch thus creating a non-canonical Notch signalling pathway. Most of the non-
canonical Notch ligands exhibit cis (cell autonomous) interaction with Notch and are mostly 
inhibitory. Inhibitory ligands bind to EGF repeats 24-29 of Notch (de Celis and Bray 2000). 
However, there are also recent studies which claim that inhibitory and activating ligand 
binding regions overlap at EGF repeats 11-12 suggesting competition of canonical and non-
canonical ligands for the same binding interfaces (Cordle, Johnson et al. 2008, Becam, 
Fiuza et al. 2010). Altogether, Notch ligands are mostly inhibitory, when they bind Notch in 
cis-configuration through EGF repeats 24-29 of the Notch receptor. Such cis-inhibitory 
ligands are thought to be important to maintain the unidirectional Notch signalling during 









Fig.2.5a Canonical Notch Signalling 
Schematic illustration of canonical Notch signalling. A trans-interaction, at EGF repeats 10-12 of 
heterodimeric Notch protein, with a canonical Notch ligand takes place. This interaction leads to 
cleavage of Notch protein near heterodimerization (HD) domain by ADAM and intracellular juxta-
membrane region by gamma secretase. The cleavage creates a free cytoplasmic Notch intracellular 
domain (NICD) which translocates into the nucleus and where it supresses the activity of repressors 






Fig.2.5b Canonical Notch Ligands 
Representation of the secondary structures of canonical Notch ligands. Classical Notch ligands 
contain the DSL (Delta-Serrate-Lag-2), DOS (Delta and OSM-11-like proteins) and EGF (Epidermal 
growth factor) motifs. DLL3 and DLL4 are considered DSL-only ligands since they lack DOS domain. 




Dlk1, the recently reported fMN marker, is structurally similar to canonical Notch ligand Dll1 
(Fig.2.5c). There are several reports of Dlk1 interacting with Notch and that Dlk1 inhibits 
Notch (Baladron, Ruiz-Hidalgo et al. 2005) as a cis-ligand (Bray, Takada et al. 2008). Yeast 
two hybrid technique shows region of interactions as EGF repeats 10-15 of Notch and EGF 
domains 5-6 of Dlk1 (Sanchez-Solana, Nueda et al. 2011, Traustadottir, Jensen et al. 2016). 
Even so, the in-vivo interaction in mammals still remain unconfirmed since most of the 
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studies are done in-vitro. Also, if the non-canonical ligand Dlk1 also binds to the canonical 
interacting regions (11-12) then how it inhibits Notch in this configuration is still unclear. 
Moreover, the idea that Dlk1 signalling operates through Notch remains contested with 
evidences suggesting failure of Dlk1 to bind to Notch and Notch-independent roles of Dlk1 
in adult neurogenesis (Ferron, Charalambous et al. 2011). Also, most of the evidences 
showing an inhibitory role of Dlk1 for Notch are indirect asserting inhibition of Notch target 
genes (Nueda, Baladron et al. 2007, Falix, Aronson et al. 2012) or failure of ligand function 





Fig.2:5c Dlk1 as a Non-Canonical Notch Ligands Compared with Canonical Ligands 
Representation of the secondary structures of canonical Notch ligands compared with the non-





2.6 Notch Signalling During Spinal Neuron Diversification 
 
Notch signalling is conducive for cell fate diversification during both vertebrate and 
invertebrate development. Notch is repetitively recruited whenever a binary fate decision is 
required throughout nervous system development. Establishment of neuronal diversity in 
central nervous system (CNS) depends on two main processes: patterning of 
neuroepithelium into discreet progenitor domains and intradomain diversification into 
neuronal and glial subtypes. During epidermal versus neural fate decisions, an inhibitory 
effect of Notch on neural fate is involved (lateral inhibition), whereas during making choice 
between different subtypes of neural cells, Notch permits one fate and prohibits the other 
(binary switch activity). For instance, it was shown that inhibition of Notch signalling induces 
premature neurogenesis (Nelson, Hartman et al. 2007) while in developing ventral spinal 
cord, Notch promotes V2b over V2a interneuron identity (Peng, Yajima et al. 2007). 
 
Enhancer of split (Esp1), a bHLH transcription factor, is a primary downstream effector of 
Notch signalling. Esp1 suppresses neuronal differentiation by inhibiting other proneural 
bHLH transcription factors (Achaete-scute and Atonal). Inhibition of Notch thus upregulates 
the transcription proneural genes leading to neuronal differentiation (Yoon and Gaiano 
2005). In addition to controlling neuron versus progenitor cell fate, Notch controls cell 
identity by temporal modulation of progenitor differentiation. For example, inhibition of Notch 
during early stages of chick retinal development (E3) results in increased population of 
ganglion cells while doing the same at later stages (E14.5) produces more amacrine cells 
(Nelson, Hartman et al. 2007). A similar temporal modulation by Notch signalling is 
observed during neuronal versus glial cell fate switch in zebrafish where a mutation in delta 
gene at early stages results in excess and early specified neurons (Appel, Givan et al. 2001) 
while conditional overexpression of Notch promoted excess of oligodendrocyte precursor 
cells (Park and Appel 2003). Studies using neurospheres clonally derived from neural stem 
cells of Dll mutant mice embryos, also revealed that Notch signalling controls the generation 
of neurons/glia from neural stem cells in a stepwise process based on temporal modulation 
(Grandbarbe, Bouissac et al. 2003). 
 
Recent studies in the p2 domain of the ventral spinal cord suggest that Notch selects 
alternative cell fates by an evolutionarily conserved mechanism of Notch dependant 
asymmetric division observed during division of ganglion mother cells (GMCs) in drosophila. 
During GMC asymmetric division, only one of the daughter cell receives ability to respond 
to Notch signalling which is generated due to asymmetrical distribution of Numb (Notch 
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inhibitor) during GMC inhibition (Frise, Knoblich et al. 1996, Spana and Doe 1996, 
Buescher, Yeo et al. 1998). Similarly, the p2 daughter cell fate is regulated by Delta4 
activation of Notch receptors and the daughter cell responsive to Notch signals activate a 
transcription factor code that specifies the v2bIN fate, whereas the daughter cell deprived 
of Notch signalling express another code for v2aIN formation (Peng, Yajima et al. 2007). 
 
Within the motor neuron progenitor domain, it has been proposed that Notch controls motor 
neuron subtype identity primarily indirectly by controlling the timing of neurogenesis and 
gliogenesis (Crawford and Roelink 2007). Another study using Gde2-null mice, suggests 
that inhibition of Notch signalling regulates subtype-specific MN generation (Sabharwal, Lee 
et al. 2011) and that loss of Notch inhibitor GDE2 led to selective loss of hypaxial (HMC) or 
lateral motor columns (LMC). This study also implied that motor neuron subtype-
specification initiates already at progenitor level when Notch is inhibited to generate post-
mitotic neurons. Consistent with this observation is another study where reduction in Notch 
signalling promoted phrenic neuron identity which is a subpopulation of HMCs (Machado, 
Kanning et al. 2014). Even more recent study utilizing embryonic stem cell (ESC) 
differentiation model (Tan, Mazzoni et al. 2016) suggests that Notch directly controls motor 
neuron subtype identity. The study demonstrates that HMC generation peaks prior to MMC 
production in the ESC-to-motor neuron differentiation system and that inhibition of Notch 
signalling leads to accelerated neurogenic differentiation of pMNs due to repression of Ngn2 
(Neurogenin2). The study also claims that MN subtype is controlled by an Ngn2-
independent mechanism and that timing of neurogenesis and control of motor neuron 
subtype identity are functionally independent processes regulated by molecularly distinct 
Notch targets. 
 
Altogether, various studies indicate Notch as a mediator of motor neuron versus glial 
differentiation and as interneuron fate selector in the ventral spinal cord. In vitro studies 
demonstrating Notch regulation of motor column identity suggests that Notch signalling may 
also regulate motor neuron functional diversity. A role for Notch in controlling functional 
diversification of motor neurons would fill a gap in our current knowledge of how motor 





2.7 NFATs as Interesting Signal Carriers from Cytosol to Nucleus 
 
Regulated influx of Ca2+ and its release from internal reserves is critical a wide range of 
biological phenomena right from beginning of life during fertilization up to muscle contraction 
during movements made by living beings and even during death. Neurons exhibit Ca2+-
dependent gene transcription patterns which is very important aspect of nervous system 
development as it makes use of a broad signalling molecule for precise functions. For 
neurons, it is important for cell-to-cell communication, synaptic activity and also long-term 
survival (Marambaud, Dreses-Werringloer et al. 2009). A key mediator of Ca2+-dependent 
gene expression is the Ca2+/calcineurin dependent transcription factor NFAT (Nuclear 
Factor of Activated T-cell). 
 
NFATs are family of transcription factors with five members: NFATc1, NFATc2, NFATc3, 
NFATc4 (Hugo Nomenclature) and NFAT5. NFATc transcription factors exist in two forms: 
a phosphorylated form which resides in the cytoplasm and a dephosphorylated form which 
is localised in the nucleus. The two forms shuttle between the nucleus and cytoplasm thus 
connecting the two compartments in response to cellular signals. These cellular signals can 
be versatile but the best-known pathway is outlined in Fig. 2.7. When intracellular calcium 
level increases to 400 nM it activates the serine/threonine phosphatase: Calcineurin via a 
calcium-binding messenger protein: Calmodulin. Calcineurin then dephosphorylates the 
cytoplasmic NFAT thus exposing its nuclear localisation signal (NLS). The 
dephosphorylated NFAT translocates to the nucleus within 5-30 minutes. In nucleus, 
NFATs form a transcription complex with other proteins or cofactors and alters gene 
transcription. Important to mention here is that NFATc transcription factors cannot directly 
bind to DNA, instead they always need another factor to bind to DNA. Hence, NFATc 
proteins integrate a calcium signal and other signal to reach a final outcome of gene 
transcription. For example, cardiac hypertrophy is caused when calcium signal triggers 
NFATc4 nuclear translocation and GATA4 binds to NFATc4 thus integrating two 
independent signals/information (calcium influx and GATA4) in the cardiac muscles 
(Molkentin, Lu et al. 1998). NFAT proteins have several interaction partners and the 
interaction can lead to either synergistic activation or repression of NFAT mediated 
transcription (Mognol, Carneiro et al. 2016). Also, different members of NFAT family have 
different specific roles which indicates that the amount of NFAT proteins activated and the 








Fig.2.7 Illustration of NFAT Signalling Pathway 
Calcium ion influx during developmental processes or cellular activities, leads to activation of 
calmodulin (CaM) which then binds and activates Calcineurin (CaN-CnB). Calcineurin being a 
phosphatase, dephosphorylates cytoplasmic NFAT and exposes its nuclear localisation signal hence 
leading to nuclear import of NFAT. In nucleus, NFAT dimerizes with other transcription factors and 
alters gene transcription. Regulation of NFAT mediated gene transcription occurs by regulation of 
Ca2+ levels; nuclear export of NFAT by a kinase GSK-3 which phosphorylates NFAT and by 
feedback control mediated by MCIP-1 (myocyte-enriched calcineurin interacting protein) which 
inhibits calcineurin. A positive feedback regulation also exists by transcription of intracellular receptor 





Like most other signalling pathways, NFAT signalling pathway is also regulated at multiple 
levels and several modulators take part in it. First regulation occurs during nuclear import 
by calcium levels, calcineurin levels and calcineurin activators/inhibitors. Secondly, once 
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NFATc is in the nucleus the nuclear export becomes regulatory because more it will stay in 
nucleus more/longer will be the transcriptional alterations. In nucleus GSK-3 (glycogen 
synthase kinase-3) is the main kinase taking part in exit of NFAT by rephosphorylating the 
protein while other kinases like p38, MAP-kinase, casein kinase and MEKK-1 are also 
known to rephosphorylate NFATc1 and NFATc3 proteins at least in vitro. The third level of 
regulation is via feedback control. For instance, NFATc2 is known to induce NFATc1 in T-
lymphocytes (Zhou, Cron et al. 2002) while in hippocampal and cortical neurons, IP3R1 
gene is induced by NFATc4 signalling (Genazzani, Carafoli et al. 1999, Graef, Mermelstein 
et al. 1999), which in turn will activate NFAT signalling by increasing intracellular calcium 
levels. Similarly, a feedback inhibition is observed in muscle cells where expression of 
MCIP-1 (a calcineurin inhibitor) transcription is activated by NFAT signalling (Yang, 




2.8 NFAT Signalling During Development of Central Nervous System 
 
 
NFAT signalling has been first implicated in lymphoid development (Shaw, Utz et al. 1988, 
Riegel, Richie et al. 1990) and was initially mostly studied in immune cells (Boom, Sol et al. 
1990). Advancements in past three decades have shown presence of different NFAT 
paralogues in different tissues during vertebrate development because NFATc proteins 
have vertebrate specific functions (Graef, Chen et al. 2001). NFAT signalling is one of those 
signalling pathways which integrates and transmits signals from cytosol to nucleus only in 
vertebrates because calcium sensitive NFAT homologs are not found in invertebrates 
(Graef, Gastier et al. 2001). Also, NFAT signalling appears to be involved in those 
developmental processes which are advanced in vertebrates e.g. lymphoid development 
(Rao and Avni 2000, Macian 2005), organisation of vascular system (Graef, Chen et al. 
2001, Nilsson, Nilsson-Ohman et al. 2008), nervous system development (Graef, Wang et 
al. 2003, Benedito, Lehtinen et al. 2005) and skeletal development (Hill-Eubanks, Gomez 
et al. 2003, Schulz and Yutzey 2004, Zhao, Irie et al. 2006, Cheng, Zhao et al. 2012). 
 
The presence of NFAT proteins in neurons was first detected in the murine nervous system 
and it indicated role of NFATs in transcription of specific neuronal genes in response to 
increases in cytosolic calcium (Ho, Jain et al. 1994). The activity of NFAT proteins in 
nervous system was first observed in hippocampal neurons (Graef, Mermelstein et al. 1999) 
where it was shown that calcium ion influx (via L-type voltage gate calcium channels and 
NMDA receptors) activates NFAT-dependent transcription. At the same time activity of 
NFATs in microglia was also reported where extracellular ATP was shown to modulate early 
gene expression within nervous system via P2Z purinoreceptor mediated activation of 
NFATs (Ferrari, Stroh et al. 1999). Soon enough, several roles of NFATs in nervous system 
development began to unravel.  It was discovered that, NFATc is required for Neurotrophin 
dependent axon outgrowth in mouse embryos (Graef, Wang et al. 2003); NFATc4 mediates 
and supports survival of granule neurons of the developing cerebellum (Benedito, Lehtinen 
et al. 2005); the morphological and electrophysiological properties of neurons depend on 
transcriptions mediated by distinct NFAT interactions (Schwartz, Schohl et al. 2009); NFAT 
signalling is important for diversification of neural crest cells and differentiation of Schwann 
cells (Kao, Wu et al. 2009). Altogether, NFATs emerged as key regulators of development 
and plasticity in nervous system but its precise role at cellular level in terms of interaction 
partners and direct influence on cellular properties remained vague due to complexity of 




Later, after discovery of the single Drosophila homolog of NFATs (dNFAT), which is 53% 
similar to NFATc2 and 64% similar NFAT5 (Keyser, Borge-Renberg et al. 2007, 
Franciscovich, Mortimer et al. 2008), NFAT was studied in simpler nervous system of 
drosophila and it was shown that dNFAT homolog is expressed widely in the nervous 
system including motor neurons; Neuronal dNFAT negatively regulated pre-synaptic bouton 
number; reduced pre-synaptic transmitter release at the neuromuscular junction; 
suppressed excitability of motor neurons and abolished synaptic plasticity (Freeman, 
Franciscovich et al. 2011). 
 
Due to established functions of NFAT signalling during development of nervous system, 
NFAT proteins were also studied in relation to nervous system disorders like Alzheimer 
disease (Abdul, Sama et al. 2009, Abdul, Furman et al. 2010), Parkinson’s disease (Luo, 
Sun et al. 2014) and Timothy Syndrome (Tian, Voineagu et al. 2014). It was shown that 
constitutively active NFAT expression in mouse model of Alzheimer’s disease recapitulates 
the phenotypes of amyloid beta (A) neurotoxicity (Hudry, Wu et al. 2012) and that 
overexpression of NFAT3 (NFATc4) significantly increased A 42 protein in SAS1 cells 
(Mei, Yan et al. 2015). On the other hand, NFAT inhibition leads to cure of Lithium-induced 
apoptosis and motor deficits observed in mouse models undergoing lithium therapy 
(Gomez-Sintes and Lucas 2010) and suppression of A induced microgliosis in Alzheimer’s 





2.9 NFAT Regulates Transcription of K+ Channels 
 
NFAT-signalling has been reported as transcriptional regulator of several ion channels in 
neurons and in muscles. A study in cardiomyocyte reported transcriptional upregulation of 
Kv4.2 channel subunits by NFAT activation (Gong, Bodi et al. 2006). Another study revealed 
that transcription of M-type K+ channels, encoded by KCNQ2-5, is regulated by NFAT 
transcription-factors organized together with A-kinase anchoring proteins (AKAPs) in 
sympathetic neurons (Zhang and Shapiro 2012). Even recent study using in-vitro models 
has provided direct evidence that NFATc4 is recruited to Kv4.2 gene promoter loci and in 
NFATc4(-/-) mice Kv4.2 transcriptional upregulation is abolished. In all these studies the 
membrane excitability of the cell was shown to be reduced due to increased K+ channel 
expression and vice-versa.  
 
Also, hyperexcitability is a norm in many Motor Neurone Diseases (MNDs). In case of Spinal 
Muscular Atrophy (SMA) for example, it has been shown that MNs derived from SMA 
patients show hyper-excitable electrophysiology (Liu, Lu et al. 2015) while similar 
hyperexcitability exits in hippocampal cortical neurons together with spinal MNs in 
(Amyotrophic Lateral Sclerosis) ALS patients (Benedetti, Ghilardi et al. 2016, Geevasinga, 
Menon et al. 2016). In all of such cases of hyperexcitability voltage gated calcium, sodium 
and potassium were held responsible and NFATs have been shown as transcriptional 
regulators of many of those channels (Chang and Martin 2016, Noto, Shibuya et al. 2016). 
Also, a role of NFAT in supporting neuronal survival is already known (Benedito, Lehtinen 
et al. 2005, Vashishta, Habas et al. 2009, Mojsa, Mora et al. 2015) which further strengthens 
the idea that lack of NFAT signalling might cause neurodegenerative disease. 
 
Altogether, inhibition of NFAT which causes hyperexcitability also resembles an unhealthy 
state of MNs and signifies the importance of NFAT in MNs where NFATc4 is significantly 
expressed as seen by in-situ hybridization (Website: © 2015 Allen Institute for Brain 
Science. Allen Spinal Cord Atlas). 
 
In case of MNs, the fast MNs differ from the gamma MNs or the slow alpha MNs primarily 
in the property of excitability. While fast MNs promoted by Dlk1 show highly reduced 
excitability, the slow MNs and the gamma MNs are easily excitable. Kcng4 transcriptional 
upregulation was shown to be responsible for the decreased excitability and increased firing 
frequency observed in Dlk1 over-expressing MNs (Muller, Cherukuri et al. 2014). Since 
KCNG4 expresses potassium channel subunit that forms functional heteromeric channels 
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with other potassium channel (Kv2.1) and also alters excitability of MNs, I hypothesized that 
induction of Kcng4 expression and reduction of excitability observed in fast MNs should 
also be possible through NFATc4 signalling pathway. Hence, a link between Dlk1 and NFAT 





2.10 Dlk1 and NFAT Linked Together in Several Different Cellular Systems 
 
Both Dlk1 and NFAT transcription factors are implicated in a number of related biological 
processes, although a direct link between Dlk1 and NFAT signalling pathway has never 
been discussed. Interestingly, a comparison of Dlk1 and NFAT functions reveals that they 
co-relate both antagonistically and synergistically depending on the tissue of reference. 
 
1. Adipogenesis: Dlk1 is known as an inhibitor of adipogenesis, since it inhibits the 
differentiation of preadipocytes to mature adipocytes (Smas and Sul 1993, Smas, 
Chen et al. 1997). In contrast to this, inhibition of NFAT transcription factors in 
preadipocytes inhibits their differentiation (Ho, Kim et al. 1998). 
 
2. Muscle Development: Dlk1 positively regulates muscle fibre growth during 
development and loss of Dlk1 in muscles decreases the number of muscle fibres 
(Charlier, Segers et al. 2001, Waddell, Zhang et al. 2010). NFATs also play 
important role in muscle fibre type specification and acts as nerve activity sensor 
leading to expression of relevant myosin heavy chains (McCullagh, Calabria et al. 
2004, Calabria, Ciciliot et al. 2009). 
 
3. Lymphocyte Development: Both Dlk1 and NFATs are important players of lymphoid 
development. On one hand expression of Dlk1 is essential for differentiation and 
function of B-lymphocytes (Raghunandan, Ruiz-Hidalgo et al. 2008) while on the 
other T-cell differentiation and function requires NFAT signalling (Macian 2005). 
 
4. Angiogenesis: Inhibition of NFAT signalling inhibited VEGF-mediated angiogenesis 
(Hernandez, Volpert et al. 2001). Recently, Dlk1 has been reported as inhibitor of 






2.11 Goals of the Present Study 
 
Our group has established Dlk1 as a determinant of MN functional diversification by 
promoting fast MN biophysical properties (Muller, Cherukuri et al. 2014). Previous 
electrophysiological studies in chick indicated that inhibition of Notch was a prerequisite for 
Dlk1 actions on MN properties (Muller, Cherukuri et al. 2014). Although inhibition of Notch 
is important, it is most likely ‘not sufficient’ to promote fast neuron properties, suggesting 
the involvement of additional factors or pathways through which Dlk1 promotes fast MN 
properties. KCNG4, a gene encoding a -subunit of a potassium channel, was identified as 
a Dlk1 dependent fast MN specific gene which contributes to the implementation of fast MN 
biophysical signature by increasing both the rheobase and firing frequency of MNs. 
However, the pathway through which expression of genes like KCNG4 are altered by the 
type I transmembrane protein Dlk1 remained unresolved. 
 
 Based on a Split-Ubiquitin two-hybrid screen for Dlk1 interaction partners, several potential 
Dlk1 interaction partners were identified including Notch1 and NFATc4. As already 
described, NFATc4 is Ca2+ dependent carrier of signals cytosol to nucleus where they 
directly regulate gene expression. Since Dlk1 and NFATs were implicated in similar 
developmental pathways, my thesis is based on the working hypothesis that NFAT would 
be an essential intermediate factor of Dlk1-mediated gene expression. 
 
Because whether Dlk1 directly interacts with Notch, and whether Dlk1 would inhibit or 
activate Notch remained controversial, my thesis starts with the investigation of Dlk1-Notch 
interaction and its effects. The second goal of my thesis was to study Dlk1 and NFAT 







3.1 Laboratory consumables and plastic wares 
 
Consumables were purchased from Starlab GmbH (Ahrensburg), Eppendorf (Hamburg), 




 Primary antibodies  
 
Antibody Against Host Species Working Dilution Company 
ChAT Goat 1:200 Merck-Millipore 
Dlk1 Rabbit 1:500 Santa Cruz 
DsRed Rabbit 1:1000 Clontech 
Err3 Mouse 1:1000 Perseus Proteomics 
FLAG Tag Mouse 1:1000 Sigma 
FLAG Tag Rabbit 1:1000 Sigma 
GFP Rabbit 1:1000 Life Technologies 
GFP Chicken 1:2000 Abcam 
HA Tag Mouse 1:1000 Abcam and Sigma 
Islet1/2 Mouse 1:200 DSHB 
MMP9 Goat 1:1000 Merck-Millipore 
MNR1/2 Mouse 1:100 DHSB 
NeuN Mouse 1:1000 Merck-Millipore 
PKCdelta Mouse 1:1500 Abcam 
Tuj1 Mouse 1:1000 DHSB 
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vACHT Rabbit 1:1000 Synaptic Systems 
 
  

























1:1000 Life Technologies 
Mouse IgG2a Donkey 
488, 555, 
647 
1:1000 Life Technologies 
Mouse IgG2b Donkey 
488, 555, 
647 
1:1000 Life Technologies 
Mouse IgG1 Donkey 405 1:500 Life Technologies 
Rabbit Donkey 405 1:500 Life Technologies 
Rabbit Donkey 700 1:15000 Licor 





Phusion (thermostable polymerase) Thermo Scientific 
Restriction enzymes Thermo Scientific 
T4 DNA ligase Thermo Scientific 
Dream Taq Polymerase Thermo Scientific 
31 
 
Shrimp alkaline phosphatase Thermo Scientific 
Protein Nucleotide Kinase Thermo Scientific 
3.4 Chemicals and reagents  
 
Name Supplier Catalogue Number 
Acetic Acid Roth 6755.1 
Agar-Agar Roth 5210.4 
Agarose Roth 3810.4 
Ampicillin Natriumsalt Applichem A0839.0010 
Anode Buffer Roth L510.1 
Blocking reagent Roti-Block Roth A151.2 
Bovine serum albumin (BSA) Roth 0163.4 
Calcium Chloride x 2H2O Roth 5239.1 
Calcium Chlorid-Dihydrate Roth T885 
Cathode Buffer Roth L511.1 
Chloroform Roth 3313.1 
D+ Glucose Anhydrous Roth X997 




Diethylpyrocarbonate (DEPC) Roth K028.2 
DMEM Merck FG0445 
DMEM Gibco 10566-032 
Dimethylsulfoxide (DMSO) Roth A994.2 
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Dodecylsulfate Na-salt (SDS) Serva 20765 
DNA Ladder 100bp plus  Thermo Scientific  SM0321 
DNA Ladder 1kb plus  Thermo Scientific  SM1333 
DTT Sigma 10197777001 
dNTP Mix  Thermo Scientific  18427013 








EGTA Sigma E3889-10G 
Foetal Bovine Serum GIBCO 10270 
Glutamine Sigma G8540-100G 
Glycerol Roth 3783.2 
Glycine Roth 3908.1 
HEPES Roth HN77.5 
Isopropanol Roth  CP41.4 
Kallium Chloride Roth 6781 
L-15 medium  SAFC Biosciences  SLBC6273 
Lysogeny Broth (LB) Agar Roth X965.3 
Lysogeny Broth (LB) Medium Roth X964.3 




Magnesium Chloride-Solution Sigma M1028-100ML 
MES Running Buffer Novex NP0002 
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Methanol Roth 4627 
Methyl Sulphonate  Sigma 471356 
Mg-ATP Sigma A9187-1G 
MOPS Running Buffer Novex NP0001 
Mowiol 4-88 Roth 0713.1 
Na3-GTP Sigma G8877-1MG 
Nu-PAGE Bis-Tris Gel 4-12 % Thermo Scientific NW04122BOX 
Nonident NP40 substitute Sigma 74385 
OCT embedding medium  Tissue-Tek 25608-930 
PAGE Ruler Thermo Scientific 26616 
PAGE Ruler INR Thermo Scientific 26635 
Paraformaldehyde Roth 0335.3 
PBS pH 7.2 10X Gibco 70013-065 
PBS pH 7.2 Gibco 20012-019 
Penicillin-Streptomycin Gibco 15070063 
Phosphatase Inhibitor Cocktail Sigma P5726 
Picric Acid Sigma P6744-1GA 
Potassium Hydroxide Roth 6751.1 
Protease Inhibitor Cocktail Sigma P1860 
Proteinase K Applichem  A7932.0100 
RNAse Away MBP 7005-11 
Roti-Block Roth A151.2 
Roti-Load Roth K929 
Sodium Chloride Roth 9265.2 
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Sodium dodecyl sulphate Roth 0183.3 
Sodium Hydrogen Carbonate Roth 8551 
Sodium Hydroxide Roth T135.1 
Sucrose Roth 4621.3 
Tris-HCl Roth 9090.3 
Tris Ultra Roth 5429.3 
Triton X-100 Roth 3051.2 
Trypsin 0.05% Gibco 15400054 
Tween 20 Sigma P1379 
Venno FF super Menno 5019-ghs 
Qiazol Qiagen 79306 





3.5 Plasmids  
Vector Supplier 
Hb9-Cre (Lee, Jurata et al. 2004) 
pCAGEN Addgene Inc. 
pCAGGS::T2TP (Sato, Kasai et al. 2007) 
pCRII-TOPO Invitrogen GmbH 
pGK-Cre Addgene Inc. 





PrimeScript 1st strand cDNA synthesis Kit Takara Bio Inc. 
GeneJET Gel Extraction Kit Thermo Scientific 
pCR-IITOPO TA Cloning Kit Invitrogen GmbH 
GeneJET Plasmid Miniprep Kit Thermo Scientific 







Construct (Mus) Primers (5’-3’); Forward (F); Reverse (R) 
HA-NFATc4 full length  
F: CTCTAGACATGTACCCATACGATGTTCCAGA 





    ATTATGCTGGGGCCGCAAGCTGCGAGGATG 
R: GGCTCACGAGGTCGGCGGGTCAGGCGTGGGAGAGATG 
HA-NFATc4 
constitutively active (CA) 
F: GCTCTAGACCATGTATCCATATGATGTTC 





Name Application Developer 
Adobe Illustrator Vector Construction Adobe Inc. 
Adobe Photoshop Image Processing Adobe Inc. 




Dr. John Clements 
GraphPad Prism Data Analysis and Representation GraphPad 
Image J Image Processing 
National Institutes of 
Health 
Microsoft Office Documentation and Presentation Microsoft 
pCLAMP Patch Clamp Recording Acquisition Molecular Devices 






3.9 Animal Models for experiments 
 Chick:  Fertilized chick eggs (Lohmann LSL strain) were purchased from 
Geflügelzucht-Horstmann GmbH. According to the German “Tierschutzgesetz” 
(BGBl. I S. 1206, 1313), in-ovo chick experiments do not require animal protocol 
permission. 
 
 Mouse: The experiments were performed on mice using procedures approved by 
the animal care committee of the Bezirksregierung Braunschweig (permit no. 
G42/08 and no. T9.07), Germany. Animals were fed ad libitum and were maintained 
on a 12-hour light-dark cycle by the animal facility of the ENI-Göttingen under the 







1. Axon Instruments Digidata 1322A digitizer 
2.  Axon Instruments MultiClamp 700B Ampliier 
3.  Bio-Rad Sub-Cell GT Electrophoresis Chamber 
4.  BTX-Harvard Apparatus ECM 830 Square Wave Electroporation System 
5.  Consort EV 231 Power Supply 
6.  Custom built Faraday Cage 
7.  Custom built Micromanipulators 
8.  Eppendorf Centrifuge 5417R 
9.  Eppendorf Centrifuge 5424 
10.  Eppendorf Centrifuge 5810 R 
11.  Eppendorf Mastercycler epgradient S 
12.   Eppendorf Research Plus pipettes 
13.   Eppendorf Thermostat Plus 
14.   Harvard Apparatus Genetrode Kit Gold Plate Model 512 
15.   Intas Gel Imager 
16.   Leica CM1850 UV Cryostat 
17.   Leica S6 E Greenough stereomicroscope 
18.   Leica VT1200 S vibratome 
19.   Licor Odyssey Clx Imaging System 
20.   NanoDrop 2000 
21.   Narishige Japan PN-30 Magnetic Glass Microelectrode Horizontal Puller 
22.   New Brunswick Galaxy 170 R CO2 Incubator 
23.   Olympus SZX16 Wide Zoom Versatile Stereo Microscope 
24.   Schott KL 1500 LCD halogen light source 
25.   Stuart End-to-End Rotator SB3 1.5 ml and 50 ml 
26.   Sutter Instruments P-97 Micropipette Puller 
27.  Thermo Scientific Heracell CO2 Incubator 240 
28.  Thermo Scientific Herasafe Microbiological Safety Cabinet 
29.  Thermo Scientific XCell SureLock™ Mini-Cell Electrophoresis System 
30.  X-Cite 120 LED Fluorescence Microscope Light Source 






4.1 Molecular Cloning 
4.1.1 RNA Extraction and Synthesis of cDNA library 
 
Necessary reagents and solutions:  
 
1. Tissue 
2. QIAzol lysis reagent 
3. Chloroform 
4. Isopropanol 
5. 75% ethanol 
6. DEPC-water (0.1% DEPC in ddH2O, mix and let it sit at room temperature overnight. 
Then autoclave) 
 
 Total RNA was isolated from embryonic and adult mouse brain by single-step 
method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction 
(Chomczynski and Sacchi 1987). Tissue was homogenized in 1 ml of QIAzol lysis 
reagent per 50 mg of tissue in a 1.5 ml tube. Homogenized sample was then incubated 
for 5 minutes at 30°C. For 1 ml of QIAzol 0.2 ml of Chloroform was then added to the 
sample. Tubes were shaken vigorously for 15 seconds and incubated again for 3 minutes 
at 30°C. Sample was then centrifuged at 12000 x g for 15 minutes at 4°C. Due to 
centrifugation, phase separation takes place (Fig. 4.1.1). The aqueous phase was 
transferred to a fresh 1.5 ml tube. 0.5 ml of isopropyl alcohol per 1 ml of QIAzol was added 
to the aqueous phase and incubated at 30°C for 10 minutes. After incubation, it was again 
centrifuged at 12,000 x g for 10 minutes at 4°C. After centrifugation, RNA is concentrated 
as pellet, so supernatant was removed and pellet was washed with 75% ethanol (1 ml for 
1ml of QIAzol). After washing and removal of alcohol by centrifugation, pellet was allowed 
to dry for 5-10 minutes. The pellet was then dissolved in 100 μl of DEPC-water (RNAase 







Fig.4.1.1: Phase separation and RNA isolation 
The homogenate is separated into 3 phases: an aqueous phase, an organic phase and an 
intermediate phase. In the aqueous phase, only RNA is present, and DNA and protein are present 
in the intermediate phase and the lower phase. The aqueous phase is collected, and RNA is 
precipitated by adding isopropanol followed by centrifugation. 
 
cDNA library was created by PrimeScript 1st-strand cDNA Synthesis Kit from TaKaRa 
as per manufacturer’s protocol using Oligo dT primers and 2 μl of total RNA. The end 





4.1.2 Polymerase Chain Reaction (PCR) 
 
Necessary reagents and solutions:  
 
1. Sterile water 
2. 100 mΜ stock of forward and reverse primers 
3. Phusion enzyme and its buffer 
4. DMSO 
5. dNTPs 
6. cDNA or template DNA 
 
 PCRs were performed as per instructions from the Thermo-Scientific user guide for 




Component 3 X 20 l Reaction Final Concentration 
Sterile Water 35.4 l  
5X Phusion HF Buffer 12 l 1X 
10 mM dNTPs 1.2 l 200 M 
DMSO 1.8 l 3 % 
10 M Forward Primer 3 l 0.5 M 
10 M Reverse Primer 3 l 0.5 M 
Template DNA / cDNA 
(0.5 g/l) 
3 l 0.025 g/l 
Phusion DNA 
polymerase 
0.6 l 0.02 U/l 






Cycle Step Temperature Time Number of Cycles 
Initial Denaturation 94°C 3 min. 1 
Denaturation 94°C 1 min. 35 
Annealing 67°C 1 min. 35 
Extension 68°C 50 seconds/Kb 35 
Final Extension 68°C 5 min. 1 
Table 4.1.2.b: Cycling Protocol 
 
The PCR was carried out in a Mastercycler epgradient (Eppendorf AG) 
4.1.3 Agarose Gel Electrophoresis 
 
Necessary reagents and solutions:  
 
1. TAE buffer: 40 mM Tris; 1mM EDTA adjust pH 7.5 with glacial acetic acid 
2. EtBr 
3. DNA molecular weight marker 
 
PCR products or mixed populations of DNA were always separated in agarose gels 
by isoelectric focussing (Takahashi, Ogino et al. 1969). 1 % (w/v) of agarose, dissolved in 
1 X TAE buffer with 3% (v/V) EtBr (1% w/V stock) was used to cast agarose gels. DNA 
samples were mixed with loading dye before loading onto the gel-wells. The molecular 
weight reference markers were used to determine the size of DNA bands, hence at least 
one well of the gel is occupied by the DNA ladder (1 Kb plus or 100 bp plus, Thermo-
Scientific).  1 X TAE buffer was also used as running buffer. The voltage used for 
electrophoresis was 5-7 V/cm. The DNA bands were observed and photographed using Gel 





4.1.4 PCR Product / DNA purification after Electrophoresis 
 
Necessary reagents and solutions:  
 
1. Thermo Scientific Gel Extraction Kit / PCR purification Kit 
 
After sufficient segregation, the DNA bands were precisely cut out from the gel with 
the help of clean & sharp blade and collected in 1.5 ml tubes. The weight of each gel sample 
was determined and the DNA was purified using Thermo-Scientific Gel Extraction Kit as per 
manufacturer’s protocol which is based on scientific discoveries (Vogelstein and Gillespie 
1979, Vogelstein 1987, Boom, Sol et al. 1990). 
4.1.5 TOPO Cloning of PCR Products 
 
Necessary reagents and solutions:  
 
1. pCRII-TOPO TA-cloning kit 
 
Purified PCR products were sub-cloned into pCRII-TOPO vector using the TA-
Cloning Kit according to the manufacturer’s protocol (Thermo-Scientific). TA-Cloning in 
pCRII-TOPO vector requires A-overhang. Hence the blunt PCR products created using 
Phusion (proofreading polymerase) were incubated with Taq polymerase to add 3’ A-





4.1.6 Preparation of chemically competent E. coli cells 
 
Necessary reagents and solutions:  
 
1. SOB media: 0.5% (w/v) yeast extract; 2%(w/v) tryptone; 10 mM NaCl; 2.5 Mm KCl; 
20 mM MgSO4 
2. Terrific Broth (TB) 
3. DMSO 
 
Competent E. coli cells of the Top10 strain (Invitrogen GmbH) were prepared 
according to the protocol demonstrated as flowchart below (Inoue, Nojima et al. 1990) and 
checked for competence by a test transformation with the pBluescript KS (-) plasmid. The 







Inoculated 250 ml of SOB medium in a 2 liter flask and grown to OD600 =0.6 
at 18°C  with vigorous shaking (200 rpm)
Spinned down cells at 2,500 x g for 10 min at +4°C
Resuspended pellet in 80 ml of ice-cold TB and incubated for 10 min, then 
spinned down cells
Resuspended pellet gently in 20 ml of TB and added DMSO to final 
concentration of 7% with gentle swirling
Dispensed cell suspension in 0.1 ml aliquots and immediately flash-freeze by 
immersion in liquid N2
Stored frozen cells at -70/80°C   
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4.1.7 Transformation of chemically competent E. coli cells 
 
Necessary reagents and solutions:  
1. Aliquot of competent cells 
2. SOB media 
3. Antibiotic containing agar plates 
 
Transformation of E. coli was performed by simple and efficient method (SEM) 
(Inoue, Nojima et al. 1990) by adding 50 μl of competent cells (thawed on ice) to a maximum 
amount of 10 μl (50 ng) of DNA solution (after TOPO cloning or Ligation). The cells were 
incubated on ice for 30 min and heat shocked at 42°C for 1 min. Afterwards they were 
chilled on ice for 2 min and 0.5 ml SOC medium was added. Subsequently they were 
incubated for 1 h on a 37°C shaker and plated on an agar plate containing the appropriate 
selection antibiotic. E. coli cells were grown over night at 37°C in an incubator. 
4.1.8 Plasmid isolation 
 
Necessary reagents and solutions:  
 
1. Thermo-Scientific Miniprep Kit / Qiagen Maxi-prep Kit 
2. Isopropanol 
 
A rapid alkaline extraction procedure was used for plasmid isolation (Birnboim and 
Doly 1979). Bacterial cells were grown from single colonies. Small-scale plasmid isolation 
was performed using 5 ml of an E. coli overnight culture using the Thermo-Scientific 
Miniprep kit according to the manufacturer’s instructions. Finally, the DNA was eluted in 40 
μl of elution buffer. 
For higher amount and purer plasmid preparations, 150 ml of E. coli liquid culture was grown 
over night. Plasmid DNA was extracted with the Qiagen Plasmid Maxi kit according to the 
manufacturer’s protocol. Concentration of nucleic acids was determined based on UV 
absorption using a Nanodrop ND-1000 UV-Vis spectrophotometer (Peqlab Biotechnologie 
GmbH). 
After successful plasmid isolation, the prescribed amount of plasmid with appropriate 






4.1.9 Restriction Digestions and Ligation 
 
Necessary reagents and solutions:  
 
1. Restriction enzymes and relevant buffers 
2. T4 Ligase and T4 Buffer 
3. Sterile water 
 
For analytical DNA digestions 2 μl (app. 500 ng) of DNA were incubated with 2 units 
(one unit cleaves 1 μg of DNA per hour) of the appropriate restriction enzyme. The 
incubation was carried out in the reaction buffer and at the temperature recommended by 
the manufacturer for 1 h. 
 
For preparative digestions 10 μg of DNA were incubated with 10 units of the restriction 
enzyme for at least three hours at the appropriate reaction temperature. If a double 
digestion was not possible according to the manufacturer’s recommendations, the DNA was 
ethanol precipitated and suspended in nuclease free water prior to the second restriction 
digest. 
To prevent religation of vector DNA leading to false positive colonies, it was treated with 
shrimp alkaline phosphatase after restriction digestion. For this, 0.5 units of the 
phosphatase enzyme were added to the restriction digest per 10 μg of DNA. Then the 
reaction mixture was incubated for 15 min at 37°C. 
 
Vector and insert DNA concentration were determined and ligation reaction was prepared 
with molar vector to insert concentrations of 1:3 to a total volume of 8 μl. Subsequently 1 μl 
each of T4 DNA ligase and T4 10X buffer were added. The reaction was incubated at 22°C 
for sticky end ligations or at 16°C for blunt end ligations for 2 h. After 2 hours the ligation 





4.1.10 Cryopreservation and recovery of E. coli clones 
 
Necessary reagents and solutions:  
 
1. 100% Glycerol 
2. Overnight plasmid containing E. coli culture 
 
1 ml of an E. coli overnight culture was mixed with 0.25 ml of 100% glycerol in 1.5 
ml Eppendorf tube to create a 20% glycerol stock of the bacterial clone generated. 
Subsequently the sample was stored at -80°C until reuse. In order to regrow the culture 
approximately 20 μl of the frozen stock were grown for 12 h in 5 ml LB medium for mini-
prep DNA purification or for 16 h in 200 ml LB medium for maxi-prep purification. 
4.1.11 Ethanol Precipitation of DNA 
 
Necessary reagents and solutions:  
 
1. 3M sodium acetate (pH 5.2) 
2. Cold 100% Ethanol 
3. 70% Ethanol 
4. Sterile water or Elution buffer 
 
 This is a simple and useful method to clean DNA from impure samples or to change 
to concentration of DNA from lower to higher. For this the total volume of DNA sample is 
measured and 1/10th volume of 3M sodium acetate (pH 5.2) is added so that final 
concentration of sodium acetate is 0.3M. After mixing it well, 2.5 volumes of chilled 100% 
ethanol is added and mixed well. The complete mixture is incubated at -20°C for more than 
20 minutes and centrifuged at maximum speed for 15 minutes. The supernatant is decanted 
and pellet is washed with 70% ethanol. After air-drying the pellet for 10 minutes, pellet is 







4.2 Cell Culture 
 
 Cell culture protocols were adapted from widely used protocols and necessary 
precautions were taken based on published literatures (Hayflick and Moorhead 1961) 
Sources: 
1. Freshney, R. Ian. (1994) Culture of Animal Cells, Third Edition. Wiley Publishing, New York. 
2. Gey, G.O., Coffman, W.D., Kubicek, M.T. (1952) Tissue culture studies of the proliferative capacity 
of cervical carcinoma and normal epithelium. Cancer Research, 12:364-365. 
3. Hayflick, L., Moorhead, P.S. (1961) The serial cultivation of human diploid cell strains. Exp. Cell 
Res. 25:585-621. 
4. Sweeney, Catherine. BS Biology, SLCC-CS Biotechnology 
5. Warmke, Timothy. SLCC-AAS Biotechnology 
4.2.1 Thawing the cells 
 
Necessary reagents and solutions:  
 
1. Hela Culture Media: 10% FBS; 1% Pen-Strep; in DMEM-High Glucose 
2. PBS 
 
When vial containing cells are removed from either the liquid Nitrogen freezer, it 
should be thawed quickly. In order to prevent damage to the cells, the Hela culture media 
was warmed to 37ºC in a 15 mL falcon tube. The cells were thawed at 37ºC in the water 
bath until about ½ of the sample has melted. The vial with ethanol and the warm media was 
added dropwise to the thawed cells. The diluted cells in fresh media were then centrifuged 
at 200 rpm for 10 minutes. The supernatant after centrifugation was carefully decanted and 
the cell pellet was re-suspended in fresh Hela media. This suspension of cells was then 





4.2.2 Passaging and Maintaining a Culture 
 
Necessary reagents and solutions:  
 
1. Hela Culture Media: 10% FBS; 1% Pen-Strep; in DMEM-High Glucose 
2. PBS 
 
Cells were passaged when they reach 70 – 90% confluency. In order to 
passage these cells, old media was removed and flask was rinsed with 5 ml PBS (0.1M) 
two times using vacuum filtration. For T-75 flask I added 2 ml of 0.05% trypsin solution and 
incubate 3 minutes at 37ºC to detach the adherent cells. The trypsin reaction was then 
quenched by adding 8 ml of warm media. This media was then sucked up and dispensed a 
few times to detach and collect all the cells from flask. The whole cell suspension was then 
transferred in a 15 ml falcon tube and centrifuged at 200 rpm for 5 minutes. After 
centrifugation, supernatant was decanted and the cell pellet was suspended in 0.9 ml of 
media. 100 μl of this suspension was then added to 10 ml of fresh media in a new T-75 
flask as seed. For accurate seeding, cells were first counted and then seeded according to 
the required cell density (Table 4.2.3). The new passage number and date was noted. The 








4.2.3 Freezing Cells 
 
Necessary reagents and solutions:  
 
1. Freezing Media: 20% FBS; 10% DMSO; in DMEM-High Glucose 
2. PBS 
 
 Cells were frozen when at low passage number (P3 and P4), healthy and confluent.  
 To freeze the cells were grown in the large 75 cm2 culture flasks. When the cells 
 were ~80 – 90% confluent, freezing protocol was followed as follows: 
 Warmed PBS (-), appropriate media and freezing media in water bath. 
 Pre-labelled 18X 2 ml cryovials with the following information: 
o Cell line 
o Passage number 
o Date  
 Prepared a styrofoam-holder (cooling box with tube holders) filled with isopropanol 
to store at -80ºC. 
 Removed the media from the flask using suction. 
 Rinsed with ~ 8 mL of PBS twice. 
 Added about 1.5 mL of trypsin (0.05%) and placed the flask in the incubator for 3 
minutes until they detach. 
 The trypsin reaction was quenched by adding 8 ml of warm media and collected all 
the cells from flask into a 15 ml falcon tube. 
 Centrifuged at 200 rpm for 5 minutes, then supernatant was discarded completely 
leaving the large pellet of cells behind. 
 19 ml of freezing media was then added to the pellet and cells were dispensed 
several times to create a homogenous suspension of cells. 
 Added 1mL of the suspended cells in freezing media to each of the labelled 
cryovials. Placed the cap on tightly. 
 Placed each tube in the styrofoam holder and closed the lid tightly. 
 The complete styrofoam holder with 18 tubes was placed in -80ºC refrigerator for 24 
hours. 
 After 24 hours, the frozen cryovials were removed from styrofoam holder and placed 







Necessary reagents and solutions:  
 
1. Lipofectamine 2000 




 Lipofectamine 2000 was used as per manufacturer’s protocol to transfect cells in 6 
well plates. Cells were grown to 80% confluency in a 6 well plate. Transfections were done 
in the laminar flow. 2 hours prior to transfection the growth media from each of the wells 
was removed and replaced with serum free DMEM media. For each well 1 tube with 100 μl 
of Optimem was aliquoted in 1.5 ml tubes. 2 μg of desired plasmid for each well was added 
in respectively labelled tube with Optimem. In a separate tube 100 x 6 (no. of wells) 
Optimem was taken to dilute 6 μl/well of Lipofectamine i.e. 24 μl Lipofectamine in 600 μl of 
Optimem media. Diluted plasmid and diluted Lipofectamine were incubated at room 
temperature for 5 minutes and then 106 μl of diluted Lipofectamine was added into each 
tube containing plasmid. The Lipofectamine-DNA mixture was further incubated for 
minimum of 25 minutes before finally adding into each well dropwise. The 6 well plate was 
then placed in incubator. After 6-8 hours the serum free media was replaced with complete 





4.2.5 Cell lysis for protein extraction 
 
Necessary reagents and solutions:  
 
1. Ice cold PBS 
2. Lysis Buffer: 0.32M Sucrose, 3mM CaCl2, 2mM MgOAc, 0.1 mM EDTA, 10 mM DTT,
 0.5% NP-40 Substitute 
3. Protease Inhibitor Cocktail 
4. Phosphatase Inhibitor Cocktail 
 
 The transfected 6-well plates lysed for protein extraction after 60 hours of 
transfection. The 6-well plate was kept on cooling gel pack. Media was sucked out with the 
help of vacuum filtration and 1 ml of ice-cold PBS was added in each well for washing of 
the cells. PBS was also removed with vacuum-filtration. After 2 more such washings, 60-70 
μl of lysis buffer (freshly supplemented with protease inhibitors) was added into each well. 
Cells from each well scraped and collected in separate 1.5 ml labelled tubes and kept 
immediately in tube mini-coolers. After careful collection, all tubes containing cell lysates 
were then kept on ice for 20 minutes for complete lysis of cells. After 20 minutes, all samples 
were centrifuged at 12000 rpm for 10 minutes at 4°C. After centrifugation, cell debris is seen 
as white pellet in the bottom while the whole cell protein lysate is present in clear 
supernatant. The supernatant is then carefully transferred to new tubes for further analysis 







Necessary reagents and solutions:  
 
1. Tris Buffer Saline (TBS): 50 mM Tris, 150 mM NaCl, pH 7.5 
2. TBS-T: TBS with 0.05% Tween-20 
3. Lysis buffer 
4. Anti-HA magnetic beads 
5. Elution Buffer (Thermo Scientific) pH 2.3 or 0.1M Glycine pH 2.0  
 
The Co-IP experiments were carried out using commercially available Pierce anti-HA 
magnetic beads from Thermo-Scientific, since HA-tagged proteins were used as a bait for 
pull down. Manufacturer’s protocol was carefully followed with slight modifications. The 
beads were mixed well before use. 
 
15 μl of anti HA beads were placed in a low protein bind 1.5 ml tube for each sample of cell 
lysate (protein). To the beads 85 μl of 0.05% TBS-T was added and mixed. Tubes were 
placed in magnetic stand for 30 minutes and the supernatant was removed. Then tubes 
were removed from magnetic stand and 100 μl of lysis buffer used for lysis of cells was 
added to the beads. After mixing, again the buffer was magnetically separated from beads 
and supernatant was discarded. After one more such washing, 70-90 μl of cell lysate 
containing HA tagged protein was added to the beads and incubated on end-over-end 
rotator for 3 hours at 4°C. After 3 hours, beads were separated magnetically and unbound 
sample lysate was collected in separate tube for analysis. To the beads, 200 μl of TBS-T 
was added for washing. Washing step was repeated and TBS-T was discarded completely 
with the help of pipette. 
 
For elution of proteins bound to the beads, acidic elution protocol from the manufacturer 
was used. 15 μl of elution buffer (pH 2.3), was added to the beads and after mixing it was 
incubated at 37°C for 10 minutes. The supernatant was collected in fresh tubes after 
magnetic separation and another round of elution with additional 15 μl of buffer was carried 
out. Final volume of 30 μl of eluted protein was collected and to this 10 μl of 4X Roti-Load 
buffer from Roth was added and mixed. This final mixture was boiled at 95°C for 5-6 
minutes. 
 




Alternate elution of protein was done by direct boiling of beads in 40 μl of 1.5X Roti-Load 
buffer. However, this protocol was used only when the antibody bands did not interfere with 
the eluted protein bands. 
4.4 SDS-PAGE 
 
Necessary reagents and solutions:  
 
1. NuPAGE 4-12% Bis-Tris Gradient Gels OR self-casted gels 
2. MES or MOPS Running Buffer 
3. PAGE Ruler 
  
 Equal amounts of protein were loaded in each well. For Co-IP experiments, 
eluted sample were always loaded together with the whole cell lysate aliquots for protein 
expression reference. The running buffer was supplied with NuPage anti-oxidant in the 
inner tank. After loading the samples and the PAGE ruler in the gel wells, a constant 




Fig.4.4: Apparatus used for SDS-PAGE 
The apparatus for SDS-PAGE shows the tank in which a precast gel is placed vertically and after 




4.5 Western Blot 
4.5.1 Wet Transfer 
 
Necessary reagents and solutions:  
 
1. Transfer Buffer: 25mM Tris; 190mM Glycine; 20% Methanol 
 
 The gel after PAGE was carefully cut-out and placed in transfer buffer for 10 
minutes. A nitrocellulose membrane was cut out with same dimensions as the gel and also 
incubated in transfer buffer for 10 minutes. After incubation, a sandwich with gel and 
membrane was prepared as shown in figure 4.5.1. This sandwich was then kept in wet 
transfer tank filled with transfer buffer and the protein was transferred on to the membrane 
by electrical force overnight at 15 mA current. 
 
 
Fig.4.5.1: Sandwich for Western Blot 
 
4.5.2 Semi-dry Transfer 
 
Necessary reagents and solutions:  
 
1. Anode Buffer 
2. Cathode Buffer 
 
 The gel after PAGE was carefully cut-out and placed in anode buffer for 10 minutes. 
A nitrocellulose membrane was cut out with same dimensions as the gel and also incubated 
in anode buffer for 10 minutes. Two thick filter papers (0.5 cm) were also incubated in anode 
and cathode buffers to support the membrane and gel respectively. Finally, a sandwich was 
prepared as shown in figure 4.5.1 and placed in semi-dry transfer chamber. Proteins were 
transferred to membrane by applying constant current of 120 mA for 2 hours.  
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4.5.3 Protein Detection by Antibody Staining 
 
Necessary reagents and solutions:  
 
1. Blocking Buffer in TBS 
2. Primary Antibodies 
3. Secondary Antibodies from Licor 
4. TBS-T 
 
 The blotted membrane after transfer was rinsed with TBS and blocked in blocking 
buffer for 1 hour. Post blocking, primary antibodies were added in blocking buffer and 
membrane was incubated in antibodies at 4°C overnight. Following day, the membrane was 
washed with TBS-T for 10 minutes three times. Membrane was then incubated in secondary 
antibodies for 1 hour and again washed 3 times. The membrane was then imaged under 





4.6 Chick Experiments 
 
In the field of developmental biology, chick embryos (Gallus gallus domesticus) are a 
classical model for studying embryogenesis and neurogenesis, because they are easy to 
access and manipulate. Moreover, the chick is a precocial species which show early 
neuromuscular maturity and mobility from the time of hatching. Due to lower generation 
time of chick and easy visualization of chick embryos. It was chosen as model system. 
 
4.6.1 The long-term expression vector utilizing Tol2 system 
 
In order to ensure high-level transgene expression within embryonic chick spinal 
cord postembryonic day 9 a novel vector system was created in our lab. This system was 
based on the tol2 transposase, which stably integrates DNA fragments into the chicken 
genome (Kawakami and Shima 1999). The tol2 transposase system requires specific 
recognition sites flanking the DNA fragment to be integrated into the genome, therefore in 
our vector system the tol2 sites are flanking the entire expression cassette. The expression 
cassette consists of pCAGGS followed by lox-stop-loxP site, multiple cloning site(MCS), 
and IRES-eGFP (Fig.4.6.1), and is referred as tol2-pCAGEN from here on. The transposase 
is introduced into the cells by co-electroporation of the transposase gene bearing plasmid 
(pCAGGS-T2TP) driving transposase expression in all cell types. To maintain expression 
specificity within motor neurons together with a high expression level the strong unspecific 
CAGGS promoter derived from the pCAGEN vector has been combined with a lox-STOP-
lox cassette consisting of two loxP recognition sites for the CRE recombinase flanking three 
beta-globin polyadenylation signals (Hoess, Ziese et al. 1982). Hb9:Cre (gift from Samuel 
Pfaff) was used in combination with the tol2-pCAGEN to express the desired gene 










4.6.2 In-ovo Injection and Electroporation of Chick Neural Tube 
 
Fertilized eggs of the Lohmann LSL strain were incubated for 65 h at 37.0°C in the 
humidity chamber (Hemel-Brutgeräte GmbH) until embryos reached Hamburger–Hamilton 
(HH) stage 18. A small hole was made in the shell on the side of the air chamber, and then 
5 ml albumin was removed from the egg using a syringe. An oval window was made in the 
eggshell to visualize the embryo (Fig.4.6.2). A micropipette was filled with 0.2% fast 
green/DNA solutions. The DNA mixture was injected into the neural tube and the embryo 
was kept moist by adding L-15 medium on top of the vitelline membrane. Unipolar 
electroporation of the DNA solution was then carried out using ECM 830 electroporator 
(Harvard Apparatus) and L-Shaped Genetrodes (5 mm in length and 0.5 mm diameter) 
conducting 25 V pulses (50 ms duration and 200 ms interval). Subsequently, the eggs were 





 Adapted from Master Thesis: Özge Demet Özçete 
Fig.4.6.2: In-ovo Electroporation of Chick Neural Tube 
A: Injection of Chick neural tube with desired DNA solution after making a small window in egg shell. 








4.6.3 Isolation of Chick embryonic spinal cord and sample preparation for IHC 
 
Necessary reagents and solutions:   
 
1. 1X PBS 
2. 4% PFA in PB 
3. 30% Sucrose in 0.1M PBS 
 
 
After the embryo reached the desired stage, the neural tube/spinal cord of embryos were 
dissected and fixed in 20 ml of 4% PFA solution for 1.5-5 hours. The PFA was then replaced 
with PBS to wash the tissue overnight. After washing, fixed tissue was dehydrated using 
30ml 30% sucrose solution until the tissue sinks to the bottom. The dehydrated tissue was 








Patch-clamp recordings to evaluate the electrophysiological properties of chick MNs 
were performed in E12.5-E13.5 chick embryos. The embryos were electroporated on 
embryonic day 2.5 with the long-term expression vector tol2-pCAGEN in combination with 
the Hb9-Cre and the pCAGGS-T2TP vector. 
 
Necessary reagents and solutions:   
 
1. Artificial Cerebral Spinal Fluid (aCSF) for chick (2 L): Always freshly prepared 
  
 NaCl  16.24 g 
 KCl  0.446 g 
 NaHCO3 2.856 g 
 Glucose 4.38 g 
 CaCl2.2H2O 1.19 g 
 MgCl2.6H2O 0.40 g 
   
 Dissolved in water to final volume of 2 L and continuously bubbled with carbogen. 
Final osmolality should be around 320. 
  
2. 2% Agarose in aCSF moulded in tubes: Prepared in advance; stored at 4°C 
 
3. 20% Gelatine in aCSF stored in syringes: Prepared in advance; stored at 4°C 
 
4. Patch Clamp Internal Solution (100 ml) pH 7.3: 
 
 This solution should be prepared completely on ice since it contains ATP and GTP. 
After making small aliquots in 1.5 ml tubes on ice, it should be immediately stored at -80°C. 









Stock Solution Mol. Wt. Per 100 ml Final Conc. 
    
KOH 8N 56.11 1.5 ml For adjusting pH to 7.3 
MeSO3H 96.11 840 μl 130 mM 
KCl 74.55 75 mg 10 mM 
MgCl2 95.2 19 mg 2 mM 
EGTA 380.4 15.2 mg 0.4 mM 
CaCl2 147 1.47 mg 0.1 mM 
HEPES 238.4 238.4 mg 10 mM 
Mg-ATP 551.14 137.8 mg 2.5 mM 
Na3-GTP 523.2 13.1 mg 0.25 mM 
 
After the solutions were ready, 200 ml of aCSF was cooled to 4-6°C on ice and vibratome 
was set up for sectioning. The chick eggs were anaesthetized on ice and dissected to isolate 
lumbar region of spinal cord. This lumbar region of spinal cord was inserted in agarose 
molds and filled with gelatine to minimize the movement of spinal cord. The mould was 
quickly moved in cold aCSF in vibratome and 300 μm thick acute slices of lumbar spinal 
cord were sectioned. The slices were then moved in aCSF at room temperature with 
continuous carbogen aeration. Acute slices were incubated in aCSF for 30 minutes before 
patch clamp recordings. 
 
Current clamp recordings were done to record electrophysiological properties of chick 
Motor-Neurons. Electroporated chick embryos expressed GFP in motor neurons along with 











4.7 Mouse animal experiments 
 
All animal experiments have been carries out in accordance with the animal protection law 
of Germany and were approved by the district government. 
The experimental animals were housed under standard conditions with access to food and 
water ad libitum. 
4.7.1 Pronuclear Injection and Mouse Line Generation 
 
Necessary reagents and solutions:  
 
1. Sterile, Purified DNA (30 μg/ml) in TE Buffer 
2. TE Buffer: 5mM Tris (pH 7.5); 0.1 mM EDTA 
3. Qiagen Maxi-prep Kit 
 
 tol2-pCAGEN- NFAT-dominant negative (NFAT-dn) plasmid was isolated from 200 
ml of bacterial culture using Qiagen Maxi-prep Kit. The plasmid was then digested using 
PshAI and SwaI restriction enzymes to remove all the bacterial promoters and resistance 
genes. The digested plasmid was then isolated via agarose gel electrophoresis followed by 
gel extraction. For elution of DNA after gel extraction only filter sterile TE buffer was used. 
The concentration of DNA was then measured with Nanodrop and final concentration of 
DNA was adjusted to 30ng/μl. 200 μl of this sterile and pure DNA was sent to animal facility 
of MPI-BPC Göttingen for pronuclear injection and mouse line generation. 
 
After the pups were born, they were tested for presence of desired gene by genotyping. 
The positive pups, after reaching adult stage, were mated with a desired Cre line of mouse 
to direct desired gene expression in desired type of cells or tissue. For present study, NFAT-
DN positive mouse were bred with Olig-Cre mice and ChAT-Cre carrying transgenic mouse 
line to express NFAT dominant negative in Olig2 positive or ChAT positive cells in nervous 





4.7.2 Mouse genotyping 
 
Necessary reagents and solutions:  
 
1. 1M Tris (pH 8) 
2. 5M NaCl 
3. 0.1M EDTA 
4. 10% SDS 
5. Proteinase K  
6. Lysis Buffer(10ml): 1ml Tris; 60μl NaCl; 20μl EDTA; 50μl SDS; 250μl Prot.K; in water 
7. Dream Taq Polymerase 
8. Primers 
 
 DNA was extracted from tail biopsies by incubation of tail tips in 500 μl lysis buffer 
overnight at 56°C. The lysate was cleared by centrifugation for 10 min at 14000 rpm and 
the supernatant was mixed with 500 μl isopropanol. Mixture was then centrifuged for 10 min 
at 14000 rpm. Subsequently, supernatant was discarded and the DNA pellet was washed 
with 500 μl 70 % Ethanol. Afterwards the DNA was dried at 37°C and 50 μl of water was 
added to dissolve the DNA pellet. 
The extracted DNA was then used as a template for genotyping. The genotyping was 
performed via PCR with the reaction components tabulated below: 
 1X (μl) 
4X 
(μl) 





10X Dream Taq 
Buffer 
2.5 10 15 17.5 22.5 27.5 32.5 
dNTPs 0.5 2 3 3.5 4.5 5.5 6.5 
100 μM Forward 
Primer 
0.5 2 3 3.5 4.5 5.5 6.5 
100 μM Reverse 
Primer 
0.5 2 3 3.5 4.5 5.5 6.5 
Dream Taq Pol. 0.125 0.5 0.75 0.875 1.125 1.375 1.625 
Sterile Water 19.875 79.5 119.25 139.13 178.87 218.62 258.37 
 
For genotyping of Mouse NFAT-DN-Olig-Cre and NFAT-DN ChAT-Cre mice, PCR reactions 
were set up for: 
1. NFAT dominant negative AND 
2. Olig-Cre OR ChAT-Cre 
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4.7.3 Isolation of Mouse embryonic tissue and sample preparation for IHC 
 
Necessary reagents and solutions:  
 
4. 1X PBS 
5. 4% PFA in PB 
6. 30% Sucrose in 0.1 M PBS 
 
 The pregnant mother mouse was sacrificed by spinal dislocation and its belly was 
cut open. The uterus was then incised carefully at one end and scissors were then inserted 
to widely open the uterus lengthwise. All embryos were then collected carefully in cold PBS. 
The embryos were washed in PBS and their heads were removed. The trunks of the 
embryos were then fixed in 30 ml of 4 % PFA for 2 hours. After 2 hours, PFA was replaced 
with PBS for overnight washing. The following day, PBS was replaced with 30% sucrose 
and incubated until the trunks sank to the bottom. After sinking, the tissue was ready for 
embedding and storage for further processing. 
 
4.7.4 Isolation of Mouse postnatal tissue and sample preparation for IHC 
 
Necessary reagents and solutions:  
 
1. 0.2M Phosphate Buffer (PB): 27.4g Na2HPO4.2H2O; 8.32g NaH2PO4.2H2O in 1L 
water 
2. Freshly prepared and chilled 4% PFA in PB (pH 7.3) 
 For 1000 ml of 4% PFA: Take 350 ml of water, add 25 drops of 10 N NaOH and 
 heat water to 60°C. Add 40 g of solid paraformaldehyde and dissolve on hot water 
 bath.  Cool and make the volume to 500 ml with water. Mix this solution with 
 equal amount of 0.2M PB to get 4% PFA. 
3. Ketamine-Xylazine as anaesthesia 
4. PBS 
5. 30% Sucrose in 0.1M PBS 
 
 PFA and PBS were chilled to 4°C and kept on ice. P10 or P21 mice were sacrificed 
by transcardial perfusion with 4 % PFA under deep ketamine (100mg/kg) -xylazine 
(10mg/kg) anaesthesia. The mice were anesthetized with ketamine-xylazine anaesthesia 
and after few minutes, they were checked for the presence of reflexes. When the reflexes 
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were totally absent, the heart was exposed and a needle connected to the tubing from a 
perfusion pump with circulating ice-cold PBS, was inserted into the left ventricle. The atrium 
was then cut with a sharp pair of scissors. This allowed for the flushing of the blood from 
the system. After three minutes of perfusion with ice-cold PBS, the tubing was moved to 
ice-cold 4 % PFA. The pump was stopped while the tubing was shifted to limit the inclusion 
of air bubbles. The animal was then perfused with PFA for 7 min (P10 mice) or 10 min. 
(P21) mice. Flow rate during the whole experiment was kept at 8.5ml/min. After the 
completion of 10 minutes, the animal was eviscerated and a ventral laminectomy was 
performed to remove the whole spinal cord (all levels) and muscles. The spinal cord was 
post fixed for an additional three hours in 4 % PFA at 4°C. Then it was washed with PBS 
for 15 hours on a shaker. After washing, the spinal cord was transferred to 30 % sucrose 
solution and was incubated at 4°C until the floating tissue sank to the bottom. Tissue was 
then removed from sucrose and embedded in OCT compound to form a cryo-block. The 








4.8 Embedding tissue in Cryo-molds and Cryo-sectioning 
 
Necessary reagents and solutions:  
 
1. O.C.T. Compound 
 
The fixed and dehydrated tissue was immersed in OCT compound for 1 minute to 
equilibrate. Meanwhile, cryomolds were labelled with description of tissue, age of tissue and 
date. Cryomolds were then filled with OCT and tissue was placed in the mold with desired 
arrangements and orientation. The cryo-mold containing OCT and tissues was then rapidly 
frozen at -80°C and stored at -20°C until use. 
 
For cutting, the solidified OCT blocks were removed from the molds and mounted in a CM 
1510 S cryostat (Leica Microsystem GmbH). 10-60 μm thick sections were sectioned and 
collected on glass slides (SuperFrost Plus). The slides were labelled with mold description, 
thickness of section and date. Then they were air dried for 30 minutes at room temperature 




4.9 Immunohistochemistry (IHC) 
 
Necessary reagents and solutions:  
 
1. PBS 1X 
2. PBS-T (1XPBS with 0.01 % TritonX100) 
3. Protein Block: 1% BSA; 0.5% TritonX100 in PBS 
4. Antibodies 
5. Mowiol 4-88 mounting medium* 
 
Cryo-sections on slides were rinsed thrice for 10 min with PBS at room temperature. 500 μl 
of protein block was applied to each slide at room temperature for 30 minutes. Appropriate 
amounts of primary antibodies were diluted in 500 μl of protein block. Protein block was 
then drained from the slides and 500 μl of diluted primary antibodies were added. The slides 
with primary antibodies were incubated overnight in cold room. The following day, slides 
were rinsed with PBS-T three times for 10 minutes. Appropriate amount of target species 
specific secondary antibodies was diluted in 500 μl of protein block. Diluted secondary 
antibodies (500 μl) were then added to the slides for 1 hour at room temperature. After one 
hour, slides were washed two times with PBS-T and once with PBS for 10 minutes. PBS 
was completely drained out and 50 μl of Mowiol mounting medium was added. Slides were 
carefully covered with cover slip, preventing any bubble and incubated at 37°C for 30 
minutes for Mowiol to solidify. After solidification of Mowiol, slides were ready for image 





* Add 2.4 g of Mowiol 4-88 to 6 g of glycerol. Stir to mix. Add 6 mL of H2O and leave for several hours 
at room temperature. Add 12 mL of 0.2 M Tris-Cl (pH 8.5) and heat to 50°C for 10 min with occasional 
mixing. After the Mowiol dissolves, clarify by centrifugation at 5000g for 15 min. For fluorescence 
detection, add DABCO (1,4-diazabicyclo-[2,2,2]-octane) to 2.5% to reduce fading. Aliquot in airtight 
containers and store at −20°C. Stock is stable at room temperature for several weeks after thawing. 
Cold Spring Harbor Protocols (2006)  
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4.10 Image Acquisition 
 
Confocal fluorescence images were taken on a Zeiss LSM 710 confocal laser scanning 
upright microscope Using a 20x / 0.8 Plan-Apochromatic air objective for overviews and a 
40x /1.3 and a 63x / 1.4 plan-apochromatic oil objectives for high resolution images. 
Fluorescent dye excitation at 488 nm, 561 nm, and 633 nm was provided by Ar/Kr, DPSS 
(Diode-pumped Solid-State), and He-Ne lasers, respectively. The fluorescent dye detection 
channel (PMT, photomultiplier tube) bandwidth was adjusted to 505-550 nm, 572-640 nm, 
and 655-720 nm for Alexa Fluor 488, Alexa Fluor 555, and Alexa Fluor 647, respectively. 
Images were acquired after the acquisition settings (laser power, PMT voltage and offset) 
were optimized while preventing pixel clipping. Once the acquisition parameters were 
established, they remained unchanged during the course of an experiment. The saved 
images were imported to Fiji software and were processed for adjustment of 




4.11 Luciferase Reporter Assay 
 
This assay was performed in collaboration with group of Dr. Kristine Henningfeld. In brief, 
at 4-celled stage of Xenopus laevis embryo (blastomeres), 250pg of Gal4-fused Notch1 
mRNA was injected with 10 pg. of UAS-firefly-luciferase (positive control) and 10 pg. of 
CMV-renilla-luciferase DNA into 2 of the 4 cells. The embryos were then cultured until onset 
of gastrulation (E10.5), after which they were collected in tubes. The luciferase assay was 
then performed using Dual Luciferase Reporter Kit (Promega) according the manufacturer’s 
protocol. Embryos were homogenized in 10 μl/embryo passive lysis buffer (Promega) 
followed by 15 minutes’ incubation at room temperature. After incubation, the homogenate 
was centrifuged for 10 min. at 13000 rpm. Supernatant was collected in fresh tubes and 
centrifuged again at 10000 rpm for 10 min. to remove any residual debris. 10 μl of final 
lysate supernatant was then loaded on luciferase assay well plate and measured via Centro 
LB960 luminometer (Berthold Technologies) using firefly and renilla luciferase substrates 
from the Promega Kit as per manufacturer’s protocol. Notch activation was then calculated 
by normalization with UAS-Firefly luciferase (positive control). Similarly, the activation of 
different Notch variants was calculated and for each Notch variant, its activation after co-
injection of Dll1, Dlk1 and GFP mRNA was also experimented and calculated. 
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4.12 Statistical analysis 
 
Statistical analysis and graphs were made using GraphPad Prism software. Error bars 
indicate the standard error of mean (SEM) unless otherwise stated. Significance was 






To dissect the Dlk1 signalling pathway, I have divided my study into two parts: Dlk1 
extracellular signalling and Dlk1 intracellular signalling. In sections 5.1 to 5.5 experimental 
evidences for Dlk1 extracellular interaction with Notch receptor and its influence on Notch 
activity is shown. In sections 5.6 to 5.13, the newly identified interaction of Dlk1 via its 
intracellular segment with another interaction partner, NFAT, is shown and its effects are 
documented. Before describing each experiment, I have detailed the generation of different 
protein variants in separate sections. 
 
PART-1: Dlk1 extracellular interaction 
 
5.1 Generation of Dlk1 Variants with Specific Deletions to Track the Extra and 
Intracellular signalling 
 
The longest isoform of native Dlk1, referred to here as Dlk1-WT with 385 amino acids was 
tagged with FLAG epitope at its N-terminal end to detect the expression and localisation of 
the protein by immunodetection in western blot (Fig.5.1). To study the requirement of the 
extracellular segment of Dlk1, a truncated version of Dlk1, Dlk1ΔICD, was created in which 
the intracellular segment was replaced with 6XHistidine residues. The 6XHis tag was added 
to ensure that the protein product remains anchored in the membrane. A construct 
expressing Dlk1 intracellular segment was also cloned separately to study its interactions 
with other intracellular proteins. Since the intracellular segment had only 65 amino acid 
residues and was difficult to detect after Co-IP experiments, GFP (green fluorescent protein) 
was fused N-terminal to Dlk1 along with a FLAG tag at C-terminal, to enable detection in 






Fig.5.1 Mouse Dlk1 wild type and truncated versions cloned with FLAG tag. 
A: To study the signalling mechanism of Dlk1, the Dlk1 protein was divided into two. An extracellular 
only version, Dlk1ΔICD and an intracellular only version Dlk1-ICD were cloned with N-terminal FLAG 
tag. B: A western blot picture of the protein products of each Dlk1 version is also shown with FLAG 
staining. While the Dlk1 full length shows two bands around 50kDa, the Dlk1ΔICD band is closer to 
40kDa and even shorter is Dlk1ICD-GFP (35 kDa) band as expected.   
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5.2 Generation of Notch Variants with Specific deletions to find out interacting 
regions with Dlk1 
 
While canonical Notch ligands activate Notch signalling (de Celis and Bray 1997), non-
canonical ligands tend to inhibit Notch signalling (Micchelli, Rulifson et al. 1997). The 
Abruptex region of Notch (EGF 24-29) was proposed to be required for cis-inhibitory 
interactions (de Celis and Bray 2000, Pei and Baker 2008), while another study suggested 
that EGF repeats 10-12 of Notch are responsible for cis-inhibition (Becam, Fiuza et al. 
2010). Moreover, depending on the study or system used, the non-canonical Notch ligand 
has been concluded to activate and suppress Notch signalling, while yet other studies have 
failed to detect physical interaction between Notch and Dlk1 at all (Wang, Zhao et al. 2010). 
Part of the ambiguity in these findings could be due to the use of relatively small fragments, 
rather than the entire extracellular segment of Notch, to study its interactions with putative 
ligands. 
 
Therefore, I addressed this ambiguity of Notch-Ligand interaction by testing the interaction 
of the entire Notch extracellular segment (ECD), referred to here as Notch1-WT for 
simplicity with Dlk1 using biochemical assay as well as luciferase assay. I generated 
variants of Notch1-WT from mouse by introducing different deletions (Fig. 5.2a). I 
considered dividing the Notch-ECD into two parts: the proposed Notch activating region 
(EGF 3-19) and the proposed Notch inhibitory region (LNR1-3). Hence, I generated 
truncated version of Notch1-WT with deleted LNR1-3 called as NotchΔLNR (Fig. 5.2a). 
Another truncated version lacked the activating regions EGF3-19 and was called 
NotchΔEGF (Fig. 5.2a) while a third deletion construct of Notch lacked both the activating 
regions and inhibitory regions called as NotchΔEGFΔLNR (Fig. 5.2a).  NotchΔEGFΔLNR 
was left with only few EGF repeats and dimerization domains (Fig. 5.2a). The expression 






Fig.5.2a Generation of Notch1 Truncations Lacking Putative Activating or Inhibitory 
Regions or Both.  
To study the interaction of Dlk1with Notch, several deletion constructs of native Notch1-ECD were 
generated. Notch1WT contained entire ECD of Notch including transmembrane region. In 
Notch1ΔLNR the three Lin-12 repeats were deleted. EGF repeats 3-19 were deleted in Notch1ΔEGF 









Fig.5.2b Western blot analysis of Notch1WT and truncated versions. 
Western blot analysis upon transfection into Hela cells showed stable expression and the expected 
sizes for Notch1-WT (215 kDa). NotchΔLNR (200 kDa) was expected to be 13 kDa smaller, while 
NotchΔEGF (100 kDa) expected to be 100 kDa smaller than Notch1-WT. NotchΔEGFΔLNR was 




5.3 Dlk1 Extracellular Segment Interacts with Notch Like a Canonical Notch 
Ligand 
 
Different HA-tagged Notch constructs were co-expressed with FLAG-tagged canonical 
Notch ligand Delta1 (Dll1) or FLAG-tagged non-canonical Notch ligand Delta like homolog1 
(Dlk1) in HeLa cells and a pull-down assay using anti HA magnetic beads was performed 
to test for interaction. After pull down, SDS-PAGE and western blot was performed to 
visualize the protein bands. The results of the experiment are shown in Figure 5.3a. and 






Fig.5.3a Interaction of Canonical Notch Ligand Dll1 with Native and Truncated Versions 
of Notch1 
Co-immunoprecipitation of co-expressed Dll1 with Notch1. Overexpressed FLAG-tagged Dll1 was 
immunoprecipitated from HeLa cell lysates with anti HA magnetic beads when HA-tagged Notch1 
constructs were co-expressed. Immunoprecipitation with anti-HA magnetic beads in absence of 
Notch co-expression was done as control. Co-immunoprecipitation of Dll1(red bands) with 
Notch1(green bands) was detected by western blotting using anti-FLAG antibody and anti-HA 





Dll1 is a canonical Notch ligand which induces Notch signalling by trans-activation. Dll1 
appears to bind between EGF repeats 11-12 of Notch1 (Rebay, Fleming et al. 1991, Rebay, 
Fehon et al. 1993). Since then EGF 11-12 was univocally established as the Notch-Delta 
interacting region. Few other reports suggested that Notch EGF 11-12 also binds at its own 
Abruptex region (EGF 24-29 in human Notch) to maintain inactive state (Pei and Baker 
2008). However, my results from co-immunoprecipitation experiments suggest that Dll1 
additionally interacts with other regions of Notch1. Fig. 5.3a tells that Dll1 has the capacity 
to bind Notch at both activating and inhibitory regions (NotchΔLNR and NotchΔEGF 
respectively). Not only this, Dll1 can still bind to NotchΔEGFΔLNR i.e. the EGF 20-26 of 
Notch. If we compare this to the literature, the EGF 20-26 of mouse Notch is similar to 
Abruptex region of human or Drosophila Notch. Hence, it can be concluded from figure 5.3a 
that the canonical Notch-ligand Dll1 can interact with Notch at multiple regions at EGF 
repeats region or LNR region. Therefore, I further hypothesized that activation or inhibition 
of Notch signalling after Notch-Dll1 interaction will depend on where exactly Dll1 binds. 
Experimental evidence to prove this hypothesis is provided in section 5.4. 
 
I next tested with which region of Notch1 the non-canonical ligand Dlk1 would binds to. 
Unlike what was recently reported that Dlk1 interacts at EGF 10-15 of Notch (Traustadottir, 
Jensen et al. 2016), in my experiment I confirmed that Dlk1 also binds at multiple regions 
of Notch ECD (shown in Figure 5.3b) just like its canonical ligand Dll1. It again raises the 
question whether Dlk1, which is known as Notch inhibitor, will activate Notch when bound 








Fig.5.3b Interaction of the Non-Canonical Notch Ligand Dlk1 extracellular segment with 
Native and Truncated Versions of Notch1 
Co-immunoprecipitation of co-expressed Dlk1ΔICD with Notch1. Overexpressed FLAG-tagged 
Dlk1ΔICD was immunoprecipitated from HeLa cell lysates with anti HA magnetic beads when HA-
tagged Notch1 constructs were co-expressed. Immunoprecipitation with anti-HA magnetic beads in 
absence of Notch co-expression was done as control. Co-immunoprecipitation of Dlk1ΔICD (red 
bands) with Notch1(green bands) was detected by western blotting using anti-FLAG antibody 






5.4 What Luciferase Assay Reveals About Notch-Dll1 and Notch-Dlk1 Interaction, 
Activation and Inhibition 
 
While some studies provided evidence that Dlk1 is an inhibitor (Baladron, Ruiz-Hidalgo et 
al. 2005) of Notch signalling, others suggested that Dlk1 activates Notch (Li, Tan et al. 2014) 
while yet other studies seem to deny an involvement of Dlk1 in Notch signalling at all (Wang, 
Zhao et al. 2010). To address these issues, I collaborated with Dr. Kristine Henningfeld’s 
laboratory (UMG Göttingen) to perform Notch activity assays in Xenopus laevis embryos. 
The Notch1-WT and its deletion constructs (Fig.5.2a) were fused to Gal4 and Notch 
activation was tested using a Gal4-UAS-Luciferase assay in presence and absence of Dll1 
and Dlk1. Luciferase assay is used to study gene expression and events involved in 
regulation of genes due to its extreme sensitivity which allows quantification of small 
changes in transcription (section 4.11). The result of this experiment is reported as relative 
activation of Notch with respect to its basal activation by endogenous Notch ligands (Fig. 
5.4). 
 
In these experiments, co-expression of canonical ligand Dll1 led to a very strong increase 
in Notch activity (Fig.5.4). Since Notch1 and Dll1 are forcedly co-expressed in vivo and are 
thus equally likely to interact in trans- as well as cis-configuration, transactivation of Notch 
by Dll1 appears to largely overrule cis-inhibition when both occur at the same time. In 
contrast to Dll1, Dlk1 completely suppressed both Notch1 basal activity and Notch1 
activation by Dll1 (Figure 5.4). Consistent with previous studies, both basal as well as Dll1-
mediated activation of Notch1 were abolished upon deleting a region of Notch1 containing 
EGF repeats 3-19 implicated in trans-activation (Figure 5.4). In contrast to deleting the 
trans-activation region, deleting the LNR region implicated in inhibiting Notch1 auto-
activation led to very strongly elevated basal Notch1 activity that was even higher compared 
to that resulting from Dll1 co-expression. Co-expression of Dll1 was not able to further 
elevate NotchΔLNR activity (Figure 5.4). Notably, co-expression of Dlk1 completely 
suppressed the NotchΔLNR activity, strongly suggesting that it operates as a bona fide 
suppressor of Notch activation rather than by competing with canonical ligands for binding 
the EGF10-13 trans-activation region. Indeed, Dlk1 still completely suppressed auto-
activation of Notch lacking both the LNR and EGF10 repeats, NotchΔEGFΔLNR (Figure 
5.4). Interestingly co-expression of Dll1 either with NotchΔEGFΔLNR or NotchΔLNR slightly 
yet significantly decreased Notch auto-activation, which is likely explained by the retained 
ability of Dll1 to interact with the EGF20-26 cis-inhibitory region in these constructs, 
consistent with the results I obtained through the co-IPs (see Figure 5.3a). These results 
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are further consistent with the binding of Dlk1 to both constructs detected by co-IP (see 
Figure 5.3b). Together these data seem to confirm Notch EGF3-19 and EGF20-26 as the 
respective trans-activating and inhibitory binding interfaces of Dll1, while Dlk1 suppresses 
Notch by both direct inhibitions at inhibitory regions of Notch and by competitive inhibition 




Fig.5.4 Dlk1 is a Potent Suppressor of Notch Signalling 
Vertical bars represent the activation of Notch1-Wt and its variants in presence or absence of Dll1 
and Dlk1 plotted with reference to basal Notch Activation. Dlk1 completely suppresses Notch-WT 
basal activity as well as Dll mediated Notch1-WT activation. In the absence of Dlk1, Dll1 strongly 
activates Notch and this activation is lost in case of NotchΔEGF. High level of Notch auto-activation 
is observed for NotchΔLNR. Additionally, removing EGF3-19 in NotchΔEGFΔLNR still leads to auto-
activation, although to a lesser degree. Despite deletion of EGF and LNR repeats, Dlk1 nevertheless 





5.5 Ectopic expression of Dlk1 Inhibits Notch Protein and Promotes Early Cell 
Cycle Exit in vivo in Chick Neural Tube 
 
I next decided to test whether Dlk1 would promote biological actions linked to Notch 
signalling or the inhibition of Notch signalling in vivo. I hypothesized that if Dlk1 were to 
suppress Notch signalling in neural progenitors, then it would promote cell cycle exit and 
Neuronal differentiation. Therefore, I forcedly expressed Dlk1 in the neural tube of chick 
embryos, by in ovo electroporation of E2.5 chick embryos and determined the number of 
differentiated MNs in transverse sections of chick neural tube by immunostaining. 
 
The transverse sections of chick neural tube have a GFP positive transfected side while a 
GFP negative untransfected side (Fig. 5.5 A). MNR1/2 (blue) staining determines the total 
number of motor progenitor cells including the ones which have undergone differentiation. 
Islet1/2 staining indicates only those motor neurons which have exited cell cycle. The 
quantification of MNR1/2 and Islet1/2 positive cells revealed that while the total number of 
MN progenitors remained unchanged, the Islet positive cell count was higher in transfected 





Fig.5.5 Dlk1 Induces Early Cell Cycle Exit in Chick Neural Tube 
A: Transverse section of chick neural tube at E3.5, 24 hours after electroporation of control GFP 
(n=7) and Dlk1-WT (n=9) expressing vector. B: Ratio of MNR1/2 positive cells in transfected side of 
neural tube over the untransfected side of neural tube. C: Ratio of Islet1/2 positive cells in transfected 




PART-2: Dlk1 Intracellular Signalling 
 
Because a screen by the laboratory for Dlk1 interaction partners using the yeast split-
ubiquitin two-hybrid system (DualSystems) detected interaction of the intracellular segment 
of Dlk1 with the nucleo-cytosolic NFATc transcription factors I focus in the second part of 




5.6 Dlk1 Processing and Release of its Intracellular Segment (DLK1-ICD) 
 
When expressing Dlk1 with a C-terminal epitope tag in HeLa cells and analysing the 
resulting protein product by western blotting I noticed the presence of a short Dlk1 fragment 
of 10 kDa together with the two larger bands around 50 kDa (due to its post-translational 
modifications like glycosylation or ubiquitination) corresponding to the non-cleaved Dlk1 
holoprotein (Figure 5.6), indicating that the Dlk1 intracellular segment (Dlk1-ICD) predicted 
to be around 10 kDa in size, is post-translationally cleaved from the holoprotein. Moreover, 
since Dlk1-ICD was present in similar abundance compared to the larger Dlk1 forms these 
observations suggest it is remarkably stable considering its small size. Because an artificial 
epitope-tagged construct containing the entire intracellular portion of Dlk1 was slightly larger 
than 10 kDa, Dlk1 appears to be cleaved a few residues C-terminal to the transmembrane 
segment to generate Dlk1-ICD (Figure 5.6). To exactly pinpoint the site of Dlk1 processing 
and the generation Dlk1-ICD I am in the process of collaborating with Dr. Oliver Valerius to 






Fig.5.6 Cleavage and Release of Dlk1 Intracellular Segment in HeLa cells 
Mouse Dlk1-WT expression with C-terminal FLAG tag together with FLAG-tagged Dlk1-ICD 
expression in HeLa cells: The Dlk1-ICD-FLAG has size of 11 kD. A cleaved C-terminal fragment of 





5.7 Generation of NFAT Constitutively Nuclear and NFAT Dominant Negative 
Versions of NFAT 
 
NFATc proteins consist two domains: An N-terminal regulatory domain called as NFAT-
homology region (NHR) and the C-terminal Rel-Homology Domain (RHD) which binds the 
DNA. NHR contains docking site for calcineurin and kinases while rest of the protein is 
having phosphorylation site, nuclear localisation sequence (NLS) and DNA binding RHD 
which are responsible for NFAT localisation and activity. By competing for and sequestering 
Ca2+/Calcineurin from endogenous NFAT proteins, the N-terminal portion of NFATc4 can 
act as a dominant negative inhibitor of the transcriptional activity of all proteins of the NFAT 
family (Chow, Rincon et al. 1999) Similarly, the C-terminal DNA without the transactivation 
domains contained in the N-terminal portion of NFATc4 yield a constitutively nuclear and 
perpetually active transcription factor (Chin, Olson et al. 1998, Bai and Kerppola 2011). To 
study NFAT interaction with Dlk1 and its role in motor neuron functional diversification I 
therefore generated C-terminally and N-terminally truncated versions of native NFATc4 





Fig.5.7 Construction and expression of native, constitutively-active and dominant-
negative NFATc4 
A: Based on literature, NFAT constitutively nuclear (NFAT-cn) and NFAT dominant negative (NFAT-
dn) were cloned with the outline of amino-acid residues as shown. B: A western blot picture of the 
protein products of each NFAT construct is also shown with anti-HA staining along with the protein 




5.8 Localisation of NFAT Variants in Cell culture and in Chick Embryos 
 
I confirmed the localisation of all NFAT variants both in cell culture and in the neural tube of 
chick embryos. As expected (Chin, Olson et al. 1998, Chow, Rincon et al. 1999), NFAT-dn 
expression was cytosolic as well as nuclear due to its small size, NFAT-cn was constitutively 
nuclear (Chin, Olson et al. 1998) while NFAT-wt was predominantly cytosolic in both cell 
culture (Figure 5.8a) and chick neural tube progenitor cells (Figure 5.8b). Also the 
distribution of NFAT-cn in the nucleus was not uniform, instead a punctate pattern was 




Fig.5.8a Localisation of native, dominant negative and constitutively nuclear NFATc4 in 
HeLa cells 
NFAT-wt is localised in cytosol while NFAT-cn has nuclear localization. NFAT-dn has both cytosolic 






Fig.5.8b Localisation of native, dominant negative and constitutively nuclear NFATc4 in 
the chick neural tube. 
NFAT-dn is localised in cytosol while NFAT-cn has nuclear localization. NFAT-wt has both cytosolic 




5.9 Direct Physical Interaction of the Dlk1-ICD with the C-terminal portion of 
NFATc4 
 
Upon co-expression in HeLa cells with HA-tagged NFATc4-wt or NFAT4-cn, but not when 
expressed alone, Flag-tagged Dlk1-ICD was co-immunoprecipitated by anti-HA antibody 
along with HA-NFAT4, thus confirming that Dlk1-ICD physically interacts with the C-terminal 
portion of NFATc4 (Figure 5.9). At the same time Dlk1 did not interact with the NFAT-dn 
protein (Figure 5.9), consistent with the Two-Hybrid-based screen in which Dlk1 was found 
to interact with the C-terminal portion of NFATc4. Thus, Dlk1 interacts only with that part of 
NFATc protein required for DNA binding and transactivation and thus being responsible for 
implementing NFAT-mediated signalling, together suggesting that the binding of Dlk1 would 
directly influence NFAT-signalling: either by activating or suppressing NFAT-signalling, 




Fig.5.9 Dlk1-ICD Physically Interacts with the C-terminal Portion of NFATc4 
Overexpressed FLAG-tagged Dlk1-ICD was Co-immunoprecipitated from HeLa cell lysates with anti 
HA magnetic beads only when HA-tagged NFAT-wt and NFAT-cn constructs were co-expressed. 
Immunoprecipitation with anti-HA magnetic beads in absence of NFAT co-expression was done as 
control. Co-immunoprecipitation of DlK1-ICD with NFAT was detected by western blotting using anti-
FLAG antibody (red bands) in and anti-HA antibody (green bands) scanned by Licor imaging system. 
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5.10 NFAT-cn Interacts with KCNG4 Cis-Regulatory Module 
 
A preliminary protein-DNA interaction test using a Reporter assay indicates that the 
constitutively nuclear NFAT (NFAT-cn) interacts with the cis-regulatory module (CRM) of 
KCNG4 (Fig. 5.10). When different NFAT versions were co-transfected with the KCNG4 
enhancer element fused with a reporter DNA (tomato) with minimal promoter (TATA), the 




Fig.5.10 Effect of NFAT-cn on the KCNG4 Cis-Regulatory Module 
A: NFAT binding to KCNG4-CRM (+3272 to +3483 bp) was determined by reporter assay. B: While 
the constitutively active NFAT-cn increased the expression of reporter gene, the inhibitory NFAT-dn 
did not alter the reporter expression. Fluorescence intensity measured in arbitrary units; ****: 
p0.0001 as per non-parametric t-test. Number of cells counted for each group was 50. 
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5.11 NFAT-cn Overexpressing Cells Exit from Chick Motor Column 
 
Although, NFAT had been reported to support neuronal survival and had been shown to 
express in MNs using in-situ hybridization (Website: © 2015 Allen Institute for Brain 
Science. Allen Spinal Cord Atlas), I discovered that NFAT-cn overexpressing cells exit the 
motor column. Already at E7 of chick embryonic stage, none of the NFAT-cn expressing 
cells were seen in the motor column. An example of chick neural tube section demonstrating 




Fig.5.11 Mouse NFAT-cn Overexpression is Incompatible with Motor Columnar Cell 
Localization 
Transverse section of Chick neural tube after 7 days of embryonic development when electroporated 
with tol2-lox-stop-loxp-NFAT-cn-IRES-GFP under Pgk-cre. No cells with reporter GFP or with anti-
HA staining were found in motor column. Motor column outline is shown is white dashed line in the 
overlay image. 
 






5.12 Overexpressing NFAT-dn in MNs Induces Hyperexcitability 
 
I studied the loss of function effect of NFATs by overexpressing NFAT-dn in chick spinal 
cord. It was already shown previously by our group that when Dlk1 is overexpressed in 
chicken spinal cord, it changes the electrophysiological properties of motoneurons towards 
fast signature. Fast alpha motoneurons (fMNs) are larger is size and have higher 
activation thresholds with higher firing frequencies. These intrinsic properties are reflected 
in current clamp recordings in terms of Rheobase, Input Resistance, After-hyperpolarization 
spike width (AHP1/2width), After-hyperpolarization decay time (AHP1/2dT) and firing 
frequency. Essentially, higher rheobase means higher threshold for firing, lower 
AHP1/2width and AHP1/2dT reflects ability to fire faster while input resistance represents 
the soma size of neurons i.e. larger the cell, lower will be the input resistance and vice-
versa. Also, the ability to fire faster (determined by AHP1/2width and AHP1/2dT) does not 
conclude a cell to be a faster firing MN. Firing frequency ultimately depends on several other 
factors, most essential of which is stimulus; larger the stimulus, higher will be the firing 
frequency. For example, the same cell can have two different AHP1/2width and AHP1/2dT 
values at different stimulus. Hence, AHP parameters should always be compared with a 
reference of ‘Rheobase’ i.e. if two cells with same rheobase, have different AHP1/2width 
then it can be concluded that the cell with lower AHP1/2width is a faster firing neuron. Also, 
the firing frequency should be compared always with reference to the rheobase to claim if 
an MN is a slow MN or a fast MN. Therefore, in my study I have included two sets of data 
for firing frequency: one, firing frequency at twice the threshold (i.e. Rheobase) to conclude 
a relatively slower or a faster MN and the peak firing frequency of the cell to determine the 
firing abilities of the cell at stimulus of 1000 pA. 
 
Both the rheobase and firing frequency at twice rheobase of NFAT-dn overexpressing MNs 
significantly reduce(Fig.5.12) while they retain their cell size (input resistance). Despite 
having lower rheobase, the cells have the ability to fire at higher frequency with lower 
AHP1/2width, AHP1/2dT and higher Peak firing frequency (Fig.5.12). This observation 
concluded that MNs due to overexpression of NFAT-dn become hyper-excitable and gain 
ability to fire even with very low stimulus. This observation negatively correlated to what we 
observe when Dlk1 is overexpressed i.e. Rheobase and Firing frequency at twice Rheobase 
increased. Fast MNs in general are large in size, and are recruited very late during muscle 
contraction due to their low excitability and once excited they fire with higher rates as 
compared to early recruited MNs. Overexpression of NFAT-dn pushes the MNs away from 






Fig.5.12 NFAT-dn Overexpression Induces Hyperexcitability in MNs 
A minimum to maximum box-plot with midline representing mean for all electrophysiological 
parameters. NFAT-dn (n=24) significantly reduces the Rheobase, Firing Frequency at twice 
Rheobase, AHP1/2width and AHP1/2dT as compared to control group (n=32). Peak firing frequency 
on the contrary is increased in the NFAT-dn overexpressing cells as compared to the control group. 
*: p0.05; ** p0.01; ****: p0.0001 as per non-parametric t-test.  
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5.13 NFAT-dn overexpressing MNs fail to acquire Fast MN properties 
 
A combination of input resistance vs rheobase of the motor neurons can correctly identify 
95% of the Motor unit types. For instance, fMNs have high Rheobase (Rb) and low Input 
Resistance (IR), the slow MNs have low Rb and high IR while the intermediate neurons 
have intermediate membrane properties (Zengel, Reid et al. 1985). I used to same 
combination of membrane properties of NFAT-dn overexpressing MNs to determine the 
motor unit type of these neurons. When compared with the control, I observed a reduction 
in population of neurons with high rheobase and low input resistance which correspond to 
the neurons of fast motor units. Hence, the electrophysiological study of NFAT-dn 
overexpressing MNs indicates a loss of fMN population when NFAT is inhibited in the 




Fig.5.13 NFAT-dn overexpression leads to reduction of fast MN population 
A significant reduction of fast Motor Neuron population was observed as compared to control when 
NFAT-dn was overexpressed in motor neurons. The population of neurons under the red box exhibit 
the properties of a fast MN and is approximately 28% in case of control. In case of NFAT-dn over-










5.14 Generation of Conditional NFAT-dominant Negative Mouse Line 
 
While biological effects caused by overexpression of a protein can be informative as to its 
endogenous function, it can also cause misleading artefacts. I therefore decided to study 
the requirements of NFAT in MNs by loss-of-function through stable genetic manipulation 
in mice. Several functionally redundant NFAT paralogues are expressed in MNs in mouse 
(Website: © 2015 Allen Institute for Brain Science. Allen Spinal Cord Atlas). Moreover, mice 
homozygous for NFATc3/c4 or NFATc2/c3/c4 compound null mutations were previously 
found to die around embryonic day 11 (Graef, Chen et al. 2001, Graef, Wang et al. 2003). 
To selectively study NFAT requirements in MNs, I therefore decided to use a strategy 
allowing conditional suppression of NFAT activity in MNs. To achieve this, I generated a 
transgene (Fig. 5.14a) facilitating selective expression of dominant negative NFAT (NFAT-
dn) upon co-expression with Cre-recombinase. Mice carrying the Caggs:::loxP-stop-loxP-
NFAT-dn-IRES-GFP  transgene were generated by random insertion transgenesis following 




Fig.5.14a The Transgene Introduced in Mice by Random Insertion 
Illustration of the transgene used to create a conditional NFAT-dn expressing mouse line. The entire 
expression cassette is flanked with tol2 sequences to facilitate random insertion of the transgene. 
The expression cassette contained lox-stop-lox sites to aid the selective Cre driven expression 
 
To study the role of NFAT in spinal motor neuron development I chose two Cre-driver lines 
i.e. Oligo2-cre (Zhou and Anderson 2002, Zawadzka, Rivers et al. 2010) and ChAT-cre 
(Rossi, Balthasar et al. 2011). Oligo2-Cre mice express Cre recombinase under the 
direction of the Olig2 locus in pMN progenitor cells giving rise to MNs and oligodendrocytes 
(Zhou and Anderson 2002) and MNs. Upon interbreeding the founder mice (n=2) with Oligo-
2Cre, I was able to identify a line showing stable expression of NFAT-dn in MN progenitors 
(Fig. 5.14b). Similarly combining the transgene with ChAT-Cre, expressing Cre 
recombinase in cholinergic neurons, allowed expression of NFAT-dn specifically in post 









Fig.5.14b Selective Expression of NFAT-dn in mouse MN/oligodendrocyte lineage 
Transverse sections of mouse embryos show absence or presence of GFP in spinal cord depending 
on the genotype as confirmed with PCR-genotyping. A: Wild type mice lack GFP positive cells in 
spinal cord. B: In the Oligo2-Cre: NFAT-dnlox-stop-lox mice GFP was strongly expressed in a ventral 











Fig.5.14c Targeted Expression of NFAT-dn-IRES-GFP Driven by ChAT-Cre in Post-mitotic 
MNs 
Transverse sections of mouse embryos show absence or presence of GFP in spinal cord depending 
on the genotype as confirmed with PCR-genotyping. A: Wild type mice lack GFP positive cells in 
spinal cord. B: In the ChAT-Cre: NFAT-dnlox-stop-lox mice GFP was strongly expressed in a ventral 









During development of central nervous system (CNS), hundreds of dissimilar neuron types 
are created. Establishment of this diverse population of neurons is essential since loss of 
particular classes of CNS neurons causes neurodegenerative disorders with improper 
formation of neuronal circuits. Spinal motor neurons (MNs) are one of those CNS neuronal 
subtypes for which an outline of transcriptional cascades, such as directed by Hox and Lim 
homeodomain proteins leading to formation of neuronal subclasses and types, is available. 
Spinal MNs further diversify into ‘functional’ subtypes: alpha (which in turn comprises of 
slow, fast and intermediate types), beta and gamma MNs. In recent years, several 
molecular markers have been found to identify particular subsets of MNs. For instance, 
NeuN and OPN seem to identify alpha MNs while Err3, Gfrα, Wnt7a identify gamma MNs. 
Alpha MN subtypes may be further identified by presence of MMP9, Calca, Chodl as fast 
MNs or Sv2a, PRKC as slow MNs. However, in case of all these molecular markers, a 
clear understanding of the molecules and pathways involved in acquisition of alpha, beta or 
gamma MN identity and their respective properties is largely missing. Dlk1, a type I 
transmembrane protein, was recently reported to promote fast MN properties. Loss of Dlk1 
in its knock-out mice also co-related with loss of fast MN properties while KCNG4 was 
reported as a Dlk1 target gene and intermediate factor for promoting fast alpha MN specific 
properties. Yet, how Dlk1 promotes transcription of KCNG4 remained elusive. The present 








6.1 Dlk1 Interacts with Notch and Inhibits Notch 
 
The signalling pathways that synchronise gene expression during early metazoan 
development relies, among others, on five main pathways, namely Notch, Hedgehog, 
receptor tyrosine kinase (RTK) transforming Growth factor-beta (TGFbeta), and 
wingless/WNT (Gerhart 1999). Out of these five signalling pathways, Dlk1 appears to 
specifically affect the Notch signalling pathway. It is clear from the Co-IP experiments (Fig. 
5.3a and Fig 5.3b) that Dlk1 interacts with Notch. This finding is against what was previously 
reported (Wang, Zhao et al. 2010) but a luciferase reporter assay for activation of Notch in 
presence or absence of Dlk1 (Fig. 5.4) further confirmed that Dlk1 not only interacts with 
Notch but completely abolishes any Notch activation. This observation was consistent with 
early cell cycle exit due to ectopic expression of Dlk1 observed in-ovo in chick E3.5 
embryonic neural tube (Fig. 5.5). Inhibition of Notch by Dlk1 during early embryonic neural 
tube development in chick signifies that the role of Dlk1 in MN diversification starts right 
from the beginning of spinal neuron generation. Delta-Notch signalling is already known to 
control generation of neurons and glia in step wise process (Grandbarbe, Bouissac et al. 
2003). Delta is a trans-activating Notch ligand and activation of Notch by juxtacrine Delta 
keeps the Notch expressing cell into cell-cycle. Delta expressing cells on other hand exit 
the cell cycle and differentiate into neurons. In this context, identification of Dlk1 as a cis-
inhibitor (Muller, Cherukuri et al. 2014) is an additional pathway of cell-cycle exit and 
differentiation i.e. while Delta expressing cells become neurons by lateral inhibition, Dlk1 
expressing cells become neurons by cis-inhibition thus already generating two pools of 
neurons (Delta expressing versus Dlk1 expressing) from the very beginning of neuronal 
emergence. 
 
How Dlk1 acts as a potent inhibitor of Notch remains unresolved and was not the subject of 
present study. However, from the evidence that Dlk1 is able to bind at multiple regions of 
Notch (Fig. 5.3b) more likely explanation would be as follows. Dlk1 binds to inhibitory 
regions of Notch (LNR1-3) to directly inhibit Notch by blocking the cleavage of Notch and 
further activation. In addition, binding of Dlk1 to the activating regions of Notch (EGF 6-15) 
blocks activation of Notch by its canonical trans-activating ligands such as Delta and 
Jagged. Thus Dlk1 inhibits Notch both by direct inhibition and competitive inhibition which 
exaggerates the inhibitory capacity of Dlk1.  
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6.2 Is Inhibition of Notch Sufficient for fast MN properties? 
 
Although inhibition of Notch is a prerequisite for Dlk1 activity to promote fast MN properties 
(Muller, Cherukuri et al. 2014), it remains unconfirmed whether inhibition of Notch is 
sufficient for fast MN properties. This aspect is difficult to study due to the ‘unitary function’ 
of Notch (a common, underlying molecular mechanism that is independent of 
developmental context), which makes it difficult to isolate the Dlk1-Notch inhibition for study 
of MN diversification. Additionally, a major hurdle to studying the role of Notch in the motor 
neuron progenitor domain is the lack of techniques to specifically manipulate Notch 
signalling in motor neuron progenitors. However, inhibition of Notch signalling at different 
time points of development is known to create different identities synchronizing with 
progenitor cell differentiation. During retinal development for example, early inactivation of 
Notch signalling (chick stage E3) promotes differentiation into ganglion cells while inhibition 
of Notch signalling at later stages (chick E 14.5) promotes amacrine cells (Nelson, Hartman 
et al. 2007). Similar stepwise activity of Notch is observed during neuron/glia differentiation 
where initially, Notch inhibits the neuronal fate while promoting the glial cell fate and in a 
second step, Notch promotes the differentiation of astrocytes, while inhibiting the 
differentiation of both neurons and oligodendrocytes (Grandbarbe, Bouissac et al. 2003). 
Despite of such existing examples, diversification of MNs merely due to inhibition of Notch 
seems unlikely due to the fact that MN diversification is very fine tuned and MN subtypes 
do not differ as broadly as a neuron and a glial cell or as seen between ganglion cells and 
amacrine cells. The MN subtypes actually differ at functional level but share a lot at 
molecular and anatomical level. For instance, all MNs express all the different ion channels 
and there is no sorting in positioning of alpha, beta or gamma MNs, they are mixed and can 
be found next to each other. The actual difference among the MN subtypes arises due to 
variation in composition of the different ion channels they express, the inputs they receive 
and the effectors they innervate. Moreover, differentiation and maturation of MN into 
functional subtypes occur much later than the time when progenitor cells exit cell cycle due 
to inhibition of Notch. Altogether, functional diversification of MNs entirely by time modulated 
Notch inhibition is not ‘impossible’ but knowing the complexity involved in MN diversification, 
a simpler module of Notch signalling inhibition appears to be the less likely pathway. 
 
A detailed and stepwise experiment with transient and temporal inhibition of Notch during 
early development of a model organism or during differentiation of MN progenitor cells will 




6.3 Dlk1 is Cleaved Intracellularly and the Cleaved Intracellular Segment is Stable 
 
In present study it is shown for the first time that Dlk1 is cleaved and the cleaved intracellular 
form is stable at least in Hela cells (Fig. 5.6). This observation is also partly consistent with 
the previous study that Dlk1 is cleaved, however the inconsistency is observed in the sizes 
of cleaved forms of Dlk1 (Smas, Chen et al. 1997). Although it was previously reported that 
Dlk1 is cleaved at an extracellular juxta-membrane site by TACE (Wang and Sul 2006), in 
my study it is observed that the size of stable cleaved form of Dlk1 (9 kDa) is even smaller 
than the size of Dlk1-ICD (11 kDa). This indicates that Dlk1 is also cleaved intracellularly. 
However, the enzyme responsible for the intracellular cleavage remains to be identified. 
 
Irrespective of the enzyme responsible, the cleavage of Dlk1 and its stabilisation signifies a 
function of Dlk1 intracellular segment with several possibilities. Firstly, Dlk1 intracellular 
segment can interact with several cytoplasmic proteins and alter their functions by causing 
conformational changes and alter the signalling status of its binding partner or secondly, 
changing the localisation of itself or binding partner or both together from cytoplasm to 
nucleus. The wide range of possibilities in Dlk1 signalling due to cleavage of Dlk1 is further 
expanded by the sequence analysis of Dlk1 intracellular segment which shows a weak 
nuclear localisation signal (NLS). The presence of weak NLS in Dlk1-ICD but absence of 
any DNA binding site indicates that Dlk1 is capable of translocating into nucleus and altering 






6.4 Dlk1 Interacts with the Transcription Factor NFATc4 
 
The biochemical assay of co-immunoprecipitation reveals a strong and stable interaction 
between Dlk1 intracellular segment and NFATc4 (Fig.5.9). Now this novel interaction 
revealed in this study can either demonstrate a new function that neither protein can exhibit 
by itself or Dlk1 can simply act as a modulator of NFAT transcriptional activity. In any case, 
Dlk1-NFAT interaction reveals a new signalling pathway which is significant not only in 
present context but in all those biological processes where Dlk1 and NFAT have been 
implicated together (section 2.8). In present study, interaction of Dlk1 with NFAT narrows 
the gap between a membrane protein Dlk1 and its target gene KCNG4 indicating that a 
signal which starts from Dlk1, reaches to the nucleus via cleavage of Dlk1, interaction of 
Dlk1 intracellular domain with NFAT and NFAT translocating into the nucleus as an outcome 
of interaction. It is already known from previous studies that NFATc4 upregulates voltage 
gated potassium channels (Gong, Bodi et al. 2006, Zhang and Shapiro 2012) and same 
might be the case in fast MN pools where NFATc4 is highly expressed (Allen Brain Atlas) 
and KCNG4 expression is upregulated. NFAT normally translocates into the nucleus due to 
exposure of its NLS after dephosphorylation by Calcineurin. How Dlk1 interaction alters the 
translocation of NFAT still needs to be confirmed. 
 
6.5 NFATc4 Regulates Transcription of KCNG4 
 
Using the tools of bioinformatics, we have found that NFATc4 can bind to non-coding 
regions of KCNG4 and in our sequence analysis we found 4 such regions ranging from 200-
400 base pairs (bp). A reporter assay has indicated binding of NFATc4 to 1 of the KCNG4 
non-coding region (cis-regulatory module) (Fig. 5.10). However, due to the known 
limitations of reporter assays a confirmatory Chromatin-immunoprecipitation (CHIP) assay 
still needs to be performed. Nevertheless, the indication that NFATc4 can regulate the Dlk1 
target gene KCNG4 contributes in completing the missing puzzle of how Dlk1 can alter gene 
transcription. Also, Dlk1 intracellular segment, has a weak NLS and due to its small size 
and strong interaction with NFATc4 it can possibly enter the nucleus too where it can act 
as co-regulator of NFATc4. Therefore, it will be interesting to study if Dlk1 interaction with 
NFATs alters or modifies or even adds to the regulation of customary targets of NFATs. 
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6.6 Inhibition of NFAT Induces Hyperexcitability in MNs During Chick Spinal Cord 
Development 
 
The electrophysiological recordings of chick MNs overexpressing the NFAT-dn construct 
which inhibits all isoforms of NFATs show that inhibition of NFAT induces hyperexcitability 
in MNs i.e. MNs start firing at very low thresholds (rheobase) and reach a peak firing 
frequency very easily (Fig. 5.12). Hyperexcitability is a property observed due to 
closing/reduction of voltage-gated potassium channels. Since NFATs are known to 
upregulate the transcription of potassium channels (Zhang and Shapiro 2012), 
hyperexcitability observed due to inhibition of NFAT is consistent with literature and our 
hypothesis that inhibition of NFAT will inhibit the transcription of voltage gate potassium 
channels like Kv7 and Kv4 (Yao, Zhao et al. 2016). The lowering of firing frequency at twice 
rheobase observed due to inhibition of NFAT is also consistent with our hypothesis as one 
of the component of voltage gate potassium channels have been shown to increase the 
firing frequency of MNs (Muller, Cherukuri et al. 2014). This lowering of frequency could 
also indicate a slow MN property but an increased peak firing frequency creates ambiguity. 
This ambiguity still needs to be confirmed in mouse models. Altogether, the significant 
lowering of AHP1/2 width and AHP1/2 due to inhibition of NFAT combined with the 
significant reduction in rheobase indicate that inhibition of NFAT induces hyperexcitability 
in MNs. 
 
This observation suggests a vital role of NFATs during MN development, since 
hyperexcitability of MNs indicates an unhealthy state of MNs as observed in motor neurone 
diseases (MNDs). In case of Spinal Muscular Atrophy (SMA) for example, it has been 
shown that MNs derived from SMA patients show hyper-excitable electrophysiology (Liu, 
Lu et al. 2015) while similar hyperexcitability exists in hippocampal cortical neurons and 
spinal MNs in (Amyotrophic Lateral Sclerosis) ALS patients (Benedetti, Ghilardi et al. 2016, 
Geevasinga, Menon et al. 2016). Not only that NFATc4 is known to promote neuronal 
survival (Benedito, Lehtinen et al. 2005, Vashishta, Habas et al. 2009, Mojsa, Mora et al. 
2015) but NFATs also regulate transcriptional status of MNs based on its firing activities 
(Zhang and Shapiro 2012). 
 
Altogether, NFAT appears to play a crucial role in directing and maintaining the firing 
properties of MNs during its functional diversification by regulating the transcription of ion 
channels although the effector ion-channels of NFAT regulation may vary with its binding 
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partners. In context of present study, it appears that Dlk1 is the binding partner of NFAT 
during KCNG4 transcriptional regulation. 
6.7 Does Dlk1 Function Mediate via Activation of NFAT? 
 
There remains a missing link in this study i.e. what happens when Dlk1 interacts with NFAT 
(Fig. 5.9). Although a direct evidence is still missing, in the light of current literature, it will 
not be an over-speculation to hypothesize that Dlk1 might activate NFATc4 signalling. On 
one hand a voltage gated potassium channel KCNG4 is mentioned as target of Dlk1 
signalling (Muller, Cherukuri et al. 2014), on the other NFAT binds to KCNG4 cis-regulatory 
module (Fig.5.10). Moreover, several reports already exist that NFAT signalling upregulates 
transcription of voltage gated potassium channels (Yao, Zhao et al. 2016). Combining this 
information with the current observation that Dlk1 interacts robustly with NFATc4, it is 
intuitive to claim that Dlk1 activates NFATc4 signalling to upregulate KCNG4 transcription 
in MNs which in turn will decrease the excitability and increase the firing frequency of MNs 
to promote a fast MN phenotype. 
 
 
6.8 A Model for the Novel Notch-Dlk1- NFATc4 Signalling Pathway 
 
Based on the present study together with the state of the art literature, an outline of novel 
signalling pathway (Fig. 6) shows how Dlk1 alters the electrophysiological properties of MNs 
at molecular level. Dlk1, located at the membrane, inhibits Notch receptor activation via cis-
interaction thus forcing the MN progenitor cells to exit cell-cycle. Dlk1 is further cleaved 
intracellularly by an unidentified molecule, and a soluble intracellular segment of Dlk1 (Dlk1-
ICD) is released in the cytoplasm. The Dlk1-ICD then interacts with phosphorylated NFATc4 
in cytoplasm and activates NFAT signalling. Activation of NFAT signalling leads to 
upregulated KCNG4 transcription which modifies the associated voltage gated potassium 
channels. Thus the newly differentiating MN is constituted with increased number of 
voltage-gated potassium channels which keep the MN in more hyperpolarised state and 
dampen the excitability of the neuron. Inhibition of Dlk1-NFATc4 signalling due to presence 
of dominant negative NFAT (NFAT-dn) therefore increases the excitability of MNs by 







Fig.6.8 The Novel Notch-Dlk-NFATc4 Signalling Pathway 
A preliminary outline of the events taking place in a motor neuron with reference to Dlk1. Dlk1, which 
is a type1 transmembrane protein, interacts with Notch in cis-configuration and inhibits Notch 
signalling. Further, Dlk1 is cleave at an intracellular position which generates a soluble form of Dlk1 
intracellular segment (Dlk1-ICD). Dlk1-ICD interacts with NFATc4 after which via NFAT signalling 
KCNG4 transcription is upregulated. Upregulation of KCNG4 decreases the excitability of MNs while 




6.9 Impact of Cis-inhibition of Notch by Dlk1 on the MN Diversification Process 
 
Emerging experimental evidences support that the cis-interactions (cis-activation and cis-
inhibition) can also trigger a cell-autonomous Notch signal, whose potential effects on cell 
fate decisions and patterning remain poorly understood. Although, concrete experimental 
evidences are missing, mathematically and computationally it had been shown that cis-
inhibition and not cis-activation facilitates patterning, by enabling additional periodic 
patterns like stripes and by allowing localized patterning highly sensitive to the precursor 
state and cell-autonomous bistability (Formosa-Jordan and Ibanes 2014). In the 
mathematical model it was shown that when multiple ligands compete for the same receptor 
like Notch, but have different signalling efficiencies then they result in a regulatory switch 
from activation to inhibition or vice-versa. It was argued in the mathematical model that cis-
inhibition of Notch signalling creates a positive intracellular feedback loop facilitating 
patterning and that cis-inhibition accelerates spontaneous diversification from very small 
initial variability between the precursor cells. 
 
Applying this mathematical model to the current Delta-Notch-Dlk1 signalling where both 
Delta (trans-activating) and Dlk1 (cis-inhibiting) bind to the same receptor Notch, it appears 
that Dlk1, the cis-inhibitor, will hold the capacity to drive the diversification of MN progenitor 
cells into the wide range of cells produced from pMN domain. 
 
Hence, while role of the canonical ligands of Notch like Delta and Jagged have been widely 
studied, similar amount of studies on cis-inhibitory ligands like Dlk1 will solve more 




6.10 Dlk1-NFATc4 a Novel Interaction or Different Flavour of NFAT Signalling 
 
NFATc transcription factors bind DNA as monomers (at GGAA sites), as dimers (at B-
like response elements) and as co-operative complexes (NFAT-AP1-Fos-Jun) (Hogan, 
Chen et al. 2003). The DNA-binding domain (RHD) of NFAT contains two distinct 
domains, N-terminal specificity domain (N-RHD) and C-terminal dimerization domain 
(C-RHD). The DNA-binding interactions involving N-RHD are conserved while those 
involving C-RHD is highly variable. This variability in DNA binding is due to the fact that 
NFATc proteins are not obligate dimers but can exist in multiple conformations 
depending on the interaction partners. This extra-ordinary flexibility of NFAT in DNA-
binding modulates recruitment of specific transcriptional co-regulators in contexts of 
different promoters (Lefstin and Yamamoto 1998). Examples of the many interaction 
partners of NFAT include bZIP family members (AP-1, Maf, ICER and p21SNFT), zinc 
finger proteins (GATA and EGR), the helix-turn-helix domain proteins (Oct,HNF3 and 
IRF-4), the MADS-box protein (MEF2) and the nuclear receptor PPAR-.  Hence 
interaction of Dlk1 with NFATc4 appears to be one of the many transcriptional co-
regulators involved in NFATc4 signalling and this time in context of KCNG4 regulation 





6.11 Transcriptional Regulation by NFAT Signalling 
 
NFAT contributes to diverse cellular functions and is expressed in various cell types. The 
cellular context, time and source of Ca+ signal and the resulting NFAT-complex formation 
with context-dependent partners, all contribute significantly to the NFAT-mediated 
transcriptional regulation. The gene expression is fundamentally regulated at the proximate 
promoter but the distal regulatory elements also have thorough consequences on the 
expression of most of the genes. These distal regulatory elements (enhancers or cis-
regulatory modules) are the medium of NFAT-dependent gene regulation in all the NFAT-
target genes. The NFAT binding sites are often located in non-coding regions of the gene 
which can be 5’ of the proximal promoter, within introns or 3’ of the gene. 
 
Because the source of Ca+ signal, the binding partners and even the distal regulatory 
elements change from cell to cell and are different at various points of differentiation process 
of a cell, the NFAT signalling has diverse function in wide range of cells. On one hand, 
NFAT regulates gene transcription in differentiated T cells and muscle fibres (Peng, Gerth 
et al. 2001, Kubis, Scheibe et al. 2002), on the other it also affects differentiation of T cells 
and osteoclasts. In the light of known roles of NFAT signalling in T-cell differentiation, 
osteoclast differentiation and cardiac valve development, it appears that NFAT typically 
takes part in developmental processes. Therefore, it does not come as a surprise that NFAT 
also regulates KCNG4 transcription via the non-coding intronic region detected in this study. 
In context of MN diversification, Dlk1 seems to deploy the extraordinary diverse signalling 







During my study of a signalling mechanism promoting MN diversification, I was able to 
provide evidence that, firstly Dlk1, a determinant of MN functional diversification, directly 
interacts with Notch and completely inhibits canonical Notch signalling via its extracellular 
segment. Secondly, Dlk1 is cleaved intracellularly and the intracellular segment engages in 
a robust interaction with NFATc4 as observed by Co-IP and western blots. A reporter assay 
revealed that NFAT directly binds to non-coding intronic region of the Dlk1 target gene, 
KCNG4 suggesting Dlk1 regulates KCNG4 expression through interacting with the NFAT. 
Also dominant negative NFAT, which inhibits the nuclear localization of all NFATs, induces 
hyperexcitability in MNs together with a reduction in firing frequency. These 
electrophysiological properties are in contrast to the increased firing frequency and 
decreased excitability observed when KCNG4 is overexpressed. This suggests that Dlk1-
NFAT heterodimer promote fast alpha MN specific gene expression including upregulation 
of KCNG4. Taken together the present study provides a putative pathway of how Dlk1 
affects its effectors. The present study suggests that Dlk1 might operate by coupling 
neurogenesis to MN functional diversification by physically linking the Notch and NFAT 
signalling pathways. In MN progenitor cells, Dlk1 inhibits Notch to promote cell cycle exit 
and neurogenesis while the eventual release of Dlk1 intracellular segment engages with 
NFAT signalling which upregulates expression of the modulators delayed-rectifier 









Fig.7 A Summary of the Study 
After the present study, I was able to establish the unknown interaction partners of Dlk1. Dlk1 
interaction with Notch and its inhibition was confirmed. Interaction of Dlk1 with NFAT was revealed 
in this study while translocation of NFAT after dephosphorylation was already known. A preliminary 
reporter assay also indicated regulation of KCNG4 by NFAT. Inhibition of NFAT mediated gene 
regulation leads to hyperexcitability was validate in this study while decreased excitability due to 







The beauty and the inconvenience of science lies in the fact that the more we investigate, 
the more investigation it begins to aspire for. That my study also raises many further 
questions is inevitable. Since I chose to study the step by step mechanism of Dlk1 signalling 
during MN diversification, I faced new scientific questions at every step. First of the many 
questions unresolved in this study is how Dlk1 is able to inhibit Notch? Since in my study a 
possibility of sole competitive inhibition was ruled out, it will be really interesting to test 
exactly which binding interface contributes to achieve this inhibition – and in which respect 
this binding differs from canonical Notch ligands. Second question: what is the importance 
of Notch inhibition? Although it was shown that Notch inhibition was a prerequisite for Dlk1 
activity, it remains elusive whether Notch inhibition is sufficient to promote fast MN 
properties. The third question came into picture when I recognized the intracellular cleavage 
of Dlk1 and i.e. what leads to the cleavage of Dlk1? The enzyme responsible for this 
cleavage is yet to be identified and it needs to be confirmed if the cleavage is important for 
Dlk1 activity. The fourth missing evidence regards the significance of the confirmed Dlk1 
and NFAT interaction for Dlk1 activity and MN functional diversification. For instance, can 
NFAT alter the expression of same genes in motor neurons in absence of Dlk1? And how 
does this interaction affect NFAT activity? Would this involve additional factors and/or would 
this alter the dependence of NFAT nuclear translocation on Ca2+/Calcineurin mediated 
dephosphorylation? The fifth dispute which still remains to be clarified whether Dlk1 and 
NFAT would specifically alter MN subtype dependent properties or complete MN identity? 
To address this question, we also need to identify the intermediate factors through which 
both Dlk1 and NFAT control biophysical properties. In my study, I had generated a mouse 
line that allows selective silencing of NFAT signalling in MNs that may ultimately help 
resolving at least some of these questions. Finally, it will be interesting to study whether 
Notch-Dlk1-NFAT signalling or similar mechanisms operate throughout the nervous system 
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